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Abstract 
NON-APOPTOTIC ROLES OF CASPASE-8 AND CASPASE-2 
by Brooke M Helfer 
Caspases are proteolytic enzymes involved in committing apoptosis, but through the 
studies of knockout phenotypes in mice and Drosophila, it has been speculated that 
caspases might possess additional non-apoptotic functions. 
  
We have found non-apoptotic functions for caspase-8 in both normal and tumor cell 
lines. Specifically, we found that caspase-8 promotes cell migration, adhesion, and 
Rac activation.  Subsequently, we also found that caspase-8 interacts with the p85 
subunit of PI3K.  Accompanying stimulation of motility with epidermal growth factor the 
phosphorylation of caspase-8 on tyrosine-380 is induced and this phosphorylation 
allows for p85 interaction, cell migration, adhesion, and Rac activation.  Caspase-8 
also promoted EGF-induced Erk activation, stimulating cell migration.   
 
Non-apoptotic functions also exist for caspase-2.  We demonstrate that caspase-2 
promotes cell-matrix adhesion, focal contact formation and FAK phosphorylation.  
Caspase 2 also mediates stress fiber dissolution in response to protein kinase-C 
activation.  Insights into the mechanism whereby caspase 2 influences cytoskeletal 
processes with emphasis on Rho/ROCK/LIMK/cofilin and Rho/ROCK/MLC pathways 
are discussed.   
 
These findings demonstrate a non-apoptotic function of a caspase involving signaling 
protein interactions rather than proteolysis.  This is also the first report that caspase-2 
and caspase-8 may mediate cytoskeletal functions independent of cell death. 
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1.  Migration and its role in cancer promotion 
Cell migration is a critical component in cancer progression.  Patients with cancer 
more often die from metastases than from their primary tumor [1].  Gene expression 
profiles demonstrate that genes associated with cell motility are often increased in 
carcinoma cells [2, 3].  Aspects of cell migration and the pathways that control this 
process directly affect the ability of cells to invade and metastasize [4].  Summarized 
here are some of the pathways that are integral in the process of cell migration.   
 
1.1  Types of cell migration 
Cell migration can be broken down into three main types of migration:  amoeboid, 
mesenchymal, and collective.  The first two types of migration, amoeboid and 
mesencymal are types of single cell migration that differ in how they move both 
phenotypically and mechanistically.  The third type of cell migration, collective 
migration, involves cells moving in groups, connected by cell-cell contacts [5].   
 
Amoeboid:  Amoeboid migration is a fast form of migration.  Interestingly, amoeboid 
migration lacks integrin association with matrix and involves only weak interactions 
with any form of substrate [6, 7].  These cells move via an expansion and contraction, 
crawling like mechanism and that is mainly driven through cortical actin dynamics 
signaled by RhoA and ROCK [8, 9].  Amoeboid migration is particularly useful when 
traveling through 3D matrices.  Cells employing amoeboid like migration, such as 
neutrophils and lymphocytes, and cancer cells such as small-cell lung and mammary 
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carcinomas and lymphomas, travel through matrices by squeezing through the 
extracellular matrix rather than needing to degrade it [3, 7, 10-12].   
 
Cell migration of tumors often occurs along fibers of the extracellular matrix (ECM).  
Cells employ amoeboid migration along these fibers, which often merge with blood 
vessels, where they can then intravasate into the blood stream and extravasate at a 
secondary location (reviewed in [13]).   
 
Mesenchymal:  Mesynchymal and collective migration utilize migration in the most 
commonly thought of integrin, Rac dependent manner.  Mesenchymal migration 
occurs via the 4 step process of 1. producing polarized cell projections,  2.  stabilizing 
those projections via focal contacts/adhesions,  3. cell contraction,  and 4.  rear end 
detachment resulting in forward cell migration [14, 15].    This migration is mediated by 
Rac, Rho and CDC42 promoted cytoskeletal structures.  Specifically, Rac and CDC42 
promote polarized cellular projections (lamellipodia and filopodia) and Rho mediates 
cell contractility [16-18].   
 
Lamellipodia projection of these cells has been explored as an important component 
of cell invasion [19].  Lamellipodia form toward blood vessels in response to 
chemoattractants such as EGF [19] or those secreted from macrophages [13, 20].  
Again, this migration relocates cells to blood vessels where they can enter into the 
blood stream and spread throughout the body [13].   
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Mesenchymal movement though 3D matrices is more complex than that seen with 
amoeboid migration.  Mesencymal cells require the digestion or remodeling of ECM, 
similar to collective migration, in order to move through a matrix, utilizing MMPs [21-
23].   
 
Collective migration:  Collective migration is achieved similarly to mesencymal 
migration with the difference that cells move as a sheet connected by cell-cell contacts 
and that the leading cells in the sheet pull connected cells along with them ([24] 
reviewed in [5]).  Collective migration is commonly witnessed in standard scratch 
wound healing assays, duct formation, sprouting of vasculature, and in invading 
epithelial clusters (reviewed in [5]).  Collective migration and mesenchymal migration 
will be the means of migration examined throughout the remainder of this document.   
 
1.2  Role of calpains in cell migration 
 
Calpain, a protease family that is ubiquitously expressed in cells, has several linkages 
to cell migration (reviewed in [25-27]).  Considering the requirements for cell migration 
– forming cellular projections, such as lamellipodia, securing those projections with 
new adhesions, polarization, and rear end detachment – calpain has the ability to 
impact the majority of these components [28-36].  In light of this, it is not surprising 
that cells treated with inhibitors of calpain demonstrated decreased cell migration [33, 
34].   
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Calpain’s influence over cell migration is also evident when considering its numerous 
substrates related to both cellular adhesion and migration.  Some of these substrates 
include talin, vinculin, paxillin, FAK, the EGF receptor, MLCK, and spectrin (reviewed 
in [26]).  Cellular adhesion is both positively and negatively influence by calpain.  Cell 
migration requires both the formation and dissolution of cell adhesions for successful 
migration.  Calpains positively influence adhesions when considering cell spreading.  
Accordingly, calpain is known to colocalize with the guanine exchange factor αPix.  In 
this context, when cells are treated with a calpain inhibitor, cell spreading and Rac 
activation are decreased.  This effect is able to be rescued by overexpression of αPix 
suggesting that the interaction of calpain with αPix is able to influence cell spreading 
[37].  Calpain is also associated with rear end detachment in migrating cells [38].  
Cleavage of some of the above listed cellular adhesion related proteins is related with 
a caplain mediated decrease in cellular adhesion [39].  Calpain proteolysis of paxillin 
and FAK have also been observed during cell migration [31].   
 
Membrane projections also require the presence of calpain.  Calpain knockout mice 
demonstrate abnormal membrane projections, specifically numerous thin projections 
with untimely retraction [30].  Furthermore, calpastatin inhibition of calpain inhibited 
lamellipodia projection and caused abnormal filopodia [35].  In both of these studies, 
cells demonstrated decreased cell migration.  Calpain has also been found necessary 
for the activation of Rac [28, 29], potentially explaining the lack of lamellipodia 
formation in its absence.   
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Calpain-2, based upon it mechanisms for activation, its ability to promote the aspects 
of cell motility, and the fact that it often displays increased activation or is 
overexpressed in some tumors [40-42] is an efficient tumor promoter. 
 
1.3 Erk activation in motility and calpain activation 
The MEKK1/Erk pathway is a pathway of interest because it is involved in the 
promotion of cell migration, is associated with calpain-2 activation, and is activated 
upon EGF treatment and cellular adhesion, and is involved in the regulation of 
transcription factors – it is a multifaceted pathway [43-47].  Here we will consider the 
impact of Erk activation upon motility, means for Erk activation, and the involvement of 
calpain activation in the promotion of cell migration.   
 
The Erk pathway influences cellular migration through myosin light chain kinase 
(MLCK), paxillin, FAK, and calpain signaling (reviewed [46]).  As reviewed above, 
calpain influences several aspects of cellular migration.  Erk may influence these 
pathways via the phosphorylation induced activation of calpain [48-50].  MLCK is able 
to be phosphorylated by both MEK1 and Erk [51] and is able to influence cell 
migration via focal adhesion dynamics and MLCK related cytoskeletal changes [52-
54].  Erk phosphorylation of MLCK also results in increased MLC phosphorylation and 
increased cell migration [51].  Erk influence over paxillin regulates adhesion, both 
formation and turnover by its interaction with FAK [55-57].  The relationship of FAK 
with Erk in cellular adhesion is somewhat complicated in that adhesion induced FAK 
activation promotes Erk activation (discussed below), which later results in adhesion 
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dissolution though calpain activation by Erk [58] and though Erk’s phosphorylation of 
FAK [57].   
 
Cellular adhesions can influence the activation of MEKK1/Erk via FAK to calpain [59].  
There are multiple pathways for the activation of ERK by cell adhesion.  First, FAK 
phosphorylation on Y925 by src is believed to recruit Grb2, and thus activate the 
classic Ras pathway [60, 61].  PAK and Raf-1 signaling also need to be taken into 
account in adhesion induced Erk activation.  PAK activation occurs via src and FAK 
signaling, upon integrin engagement, which then acts upstream of Erk by activation of 
MEK1 [62].    Erk supported migration is also achieved though calpain proteolysis of 
FAK for rear end detachment [46, 58].   
 
Interestingly, MEKK1 also binds directly to FAK, and may additionally bind directly to 
ERK [63].  This interaction, when activated by EGF, is able to activate Erk, and thus 
influence caplain activation and Erk mediated adhesion/motility dynamics [38].  During 
apoptosis, caspase-8 cleaves MEKK1 resulting in its activation [64].  This interaction 
may allow MEKK1 to activate Erk and influence cell migration under non-apoptotic 
circumstances also, an avenue that has yet to be explored.  
 
MEKK1/Erk activation and downstream calpain phosphorylation also occurs via EGF 
(and other growth factor) stimulated activation of the Ras pathway [49].  This pathway 
is well established and will only be described briefly.  Activation begins with EGFR 
stimulation and subsequent receptor phosphorylation.  Grb2, an adaptor protein, is 
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then able to interact with the GEF Sos to activate Ras.  Ras then activates Raf 
(MAPKKK), which then results in MAPKK to MAPK (Erk) activation [65-67].  
Interestingly, several members of the Ras pathway are also able to be induced by 
adhesion [60, 61] and reciprocally FAK can be activated by interaction with EGF, an 
interaction able to support cell migration [68].  Several pathways in which 
MEKK1/Erk/calpain activation occur are summarized in Figure 1.  Note that some of 
these pathways are predicted to be caspase-8-dependent, which has not yet been 
tested.   
 
1.4  PI3K signaling in cellular migration 
EGF stimulation is an important component in both cell migration and tumor 
metastasis.  EGFR signals the activation of several migratory pathways including Rac, 
CDC42, PI3K, and Erk [48, 49, 69-73].  The activation of these pathways occurs not 
only though activation of their specific pathways by EGF but also though pathway 
cross talk.     Deregulation of EGFR signaling would have the potential to wreak 
cellular havoc, an example being ErbB2 signaling in mammary tumors [74].  EGFR 
overexpression and signaling through EGF have been connected to both increased 
migration and invasion [75-77], including breast cancer with ErbB2 expression [78-80].   
 
The phosphatidylinositol-3-kinase (PI3K) pathway is one aspect of EGFR signaling.  
PI3K is comprised of three subfamilies, class-1 being comprised of p85 regulatory and 
p110 catalytic subunits.  The p85/110 heterodimer is stimulated by EGF and is able to 
produce the lipid products phosphatidylinositol 3-monophosphate, phosphatidylinositol 
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3,4-bisphosphate, and phosphatidylinositol 3,4,5-triphosphate (reviewed in [81, 82]).  
These lipid products, especially phosphatidylinositol 3,4,5-triphosphate (PIP3),  are 
able to influence cell migration [83, 84].  Chemoattractant stimulation of PI3K at the 
leading edge is one example of how PI3K/PIP3 influences cell migration.  PIP3 is 
associated with the activation of Rac GEFs to mediate Rac activation (reviewed in [85, 
86]) and thus cellular protrusions.  This interaction also results in CDC42 by αPix and 
Rho/ROCK cytoskeletal dynamics [86].  Through these processes, PI3K is able to 
influence the signaling between Rac, Rho, and CDC42, a pathway associated with 
coordination of lamellipodia projection (Rac), filopodia projection (CDC42), and Rho 
mediated adhesion and stress fiber modification (reviewed [15]).   
 
PI3K has the ability to activate and be activated by Ras [87-90].  Interaction of PI3K 
with EGFR [91] is able to mediate activation of the Ras pathway [92].  Through this 
interaction PI3K is able to affect Erk activation as reviewed above.  PI3K is also able 
to activate Raf-1 through Pak resulting in the RafÆMEKÆErk progression of 
activation [93, 94].  
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2.  Apoptotic functions of caspases 2 and 8 
Apoptosis is an organized way of death that occurs in a step-like process.  Apoptosis 
can be described as occurring in three steps – initiation, commitment and execution 
[95, 96].  The area of caspase research with regard to apoptosis is astounding.  Due 
to the purpose of this review, the functions of caspase-8 and caspase-2 in apoptosis 
will be reviewed briefly by emphasizing induction of apoptosis and key substrates of 
these caspases.   
 
Death receptor signaling complexes are responsible for relaying external apoptosis 
inducing signals to initiator caspases.  The DISC, which is means of activating initiator 
caspase-8, is composed of the CD95/APO1/Fas surface receptor, TRADD, and 
FADD.  Alternatively, FADD is able to bind to CD95 directly without TRADD as an 
intermediary.  Binding of FasL to CD95 results in assembly of the DISC and FADD 
mediated dimerization of caspase-8.  This complex leads to subsequent caspase-8 
activation [97] and induction of apoptosis.  Activation of caspase-8 occurs via a two 
step cleavage process.  First, the linker region between the p18 and p10 subunits of 
caspase-8 is cleaved at D374 and D384.  The second cleavage event is at D216 
releasing a mature caspase-8 tetramer from the DISC into the cytoplasm [98] (Figure 
2).  An interesting dynamic in this process is c-FLIP.  c-FLIP can inhibit apoptosis 
when recruited to a DISC because it competes against caspase-8 recruitment.  On the 
other hand, non-DISC associated caspase-8 is activated by herterodimerization with 
c-FLIP [99, 100].  
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Caspase-8 is able to induce MOMP by cleaving Bid protein [101] as well as directly 
activate caspase-3 and caspase-7 [102], which are “executioner caspases” (ie 
caspases that cleave critical survival substrates) and plectin [103]; other substrates 
and binding partners have been proposed as well (hprd.org).  Caspase-8 cleavage of 
plectin may be relevant in the induction of anoikis since plectin is a cytoskeletal 
anchoring protein.  Plectin cleavage by caspase-8 also is responsible in part for 
apoptotic reorganization of the cytoskeleton since plectin is a crosslinking protein of 
the cytoskeleton filament systems [103].     
 
Caspase-2 activation is also able to be achieved in theory via a death receptor 
signaling complex, but its main function is in DNA damage-induced apoptosis    
Caspase-2 is found in a complex with the DISC complex, and is able to be activated 
by it [104], but is not required for FAS-induced apoptosis [105].  Caspase-2 is able to 
bind to both CD95 and TNF-R1 via RIP mediated RAIDD binding to caspase-2 
through their CARD domains [106, 107].  Caspase-2 is also recruited to the 
PIDDosome, through the interaction of its caspase recruitment domain (CARD) with 
RAIDD [108].  Caspase 2 has been implicated in at least four apoptotic responses:  i.  
heat shock response [109]  ii.  “mitotic catastrophe”, that is cell death induced when 
mitotic chromosome segregation fails due to improper kinetochore attachment or 
chromosome damage. Mitotic catastrophe involves activating caspase 2 upstream of 
mitochondrial outer membrane permeabilization (MOMP) [110, 111]  iii.  DNA damage 
responses [108, 112-120]  iv.  Cytoskeletal disruption induced apoptosis [121]. 
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Caspase-2 has only a few known substrates.  Substrates of note are golgin-160 and 
Bid.  Caspase-2 cleavage of Bid is associated with the mitochondrial driven aspect of 
apoptosis, of which caspase-2 is thought to be both upstream and downstream of the 
mitochondria (reviewed in [122]).  Bid cleavage by caspase-2 at the mitochondria is 
responsible for cytochrome c release and activation of Apaf-1, which further activates 
caspase-9 and perpetuates the caspase cascade [123].  Golgin-160 cleavage also 
influences the apoptotic response in that its cleavage by caspase-2 allows its futher 
processing by other caspases and result in the disassembly of the golgi apparatus 
[124].   
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3.  Non-apoptotic functions of caspases 
Caspases, for the most part have been viewed as a cell’s death machinery.  Recently, 
functions are emerging for caspases in healthy cells as well.  Since caspases are 
present in cells at all times, it is not surprising that they have functions beyond cell 
death.  The development of these roles often begins with studies of caspases in knock 
out MEFs and in studies of homologous caspases in other animals.  Elucidation of 
non-apoptotic roles possessed by caspases also produces several trends, these 
themes and theories are the topics considered here.   
 
3.1  Caspase knockout animal studies 
The study of caspases has come a long way over the past 15 years.  Of note are 
studies done in both knock out animals and the study of caspase homologs in other 
animals such as Drosophila (reviewed below).  The reasoning that caspases are vital 
in both life and death begin in these contexts.  Caspases 3, 8, and 9 are essential for 
development and also integral in apoptosis.  While other caspases are not embryonic 
lethal, there are factors in the development of these animals that also suggest roles in 
addition to apoptosis (reviewed in [125]).   
 
The knock out of initiator caspases 2, 8, and 9 have varying results.  Caspases 8 and 
9 are lethal when their expression is knocked out.  Caspase-8 embyos are E11 
embryonic lethal due to the inability to form a functional circulatory system [125, 126].  
More specifically, the conditional knockout of caspase-8 in epithelial cells showed a 
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both circulatory failure and lack of neural tube closure [127].  Other conditional 
knockouts influenced cell differentiation and proliferation (discussed below).  Caspase 
9 knock outs were perinatally lethal.  Most mice died either before or shortly after birth 
via brain abnormalities; however some were able to survive and developed normally 
[125, 128, 129].  Contradictory to the idea that initiator caspases are essential for 
development, knocking out caspase-2 expression does not appear to have much of 
an effect on developing mice.  Female mice show an accumulation of oocytes [130] as 
their only phenotypic abnormality.  This is somewhat surprising given the dependence 
on the other initiator caspases, 8 and 9, in development and on caspase-2’s structural 
similarity to caspase-9.   
 
Caspase-3 knockouts are lethal as well [131].  Caspase-3 lethality is due to excessive 
brain tissue expansion, similar to caspase-9.  This finding is not surprising given later 
studies that determine an essential role of caspase-3 and -9 in the differentiation of 
many cell types (reviewed below), a factor that is undoubtedly an additional aspect in 
their lethality.  Caspase-3 is one of the three caspases that are thought of as 
executioner caspases.  Caspases 6 and 7 are also executioner caspases, however 
their knockouts have not been published exclusively, they have been reported as 
unpublished data, suggesting that caspase-6 is the only executioner caspase when 
knocked out results in normal development [125]. 
 
Other mouse caspase knockouts include inflammation related caspases: caspase-1, 
caspase-11, and caspase-12.  While these animals develop normally they 
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demonstrate deficient apoptosis and often defects in IL-1α and IL-1β production [132], 
roles that are not surprising given their apoptotic context.   
 
3.2  Non-apoptotic functions: Low/basal levels of caspase activity 
In some cases caspases serving non-apoptotic functions exhibit hallmarks of 
apoptosis but yet do not cause cell death, termed “incomplete apoptosis” [133].  This 
theme is present across several caspases but is most common with caspase-3, a 
caspase whose activation was once viewed as a point of no return.   
 
Caspase-3 is involved in the differentiation of lens epithelial cells into lens fibers.  The 
activation of caspase-3 is required for this to occur and results in TUNEL-positive 
nuclei and PARP cleavage.  Addition of a caspase-inhibitor prevents these processes 
from occurring suggesting further that caspase-3 activation is required [134].  
Caspase-3 is also accredited in erythroblast maturation/differentiation.  Activation of 
caspase-3 occurs via the mitochondrial pathway and cleaves lamin B, an important 
step in the dissolution of the nuclei [135, 136].  Interestingly, both caspase-3 and 9 are 
associated with compartmentalized monocyte to macrophage differentiation.  This 
activation is present in monocyte to macrophage differentiation but not in monocyte to 
dendritic cell differentiation.  This activation is also in the absence of PARP cleavage.  
This is unique because PARP cleavage, a hallmark of apoptosis, does not occur but 
cytochrome-c release and Acinus activation [137], and thus can be characterized as 
both apoptosis independent and exhibiting “incomplete apoptosis”. 
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Caspase-14 is also involved in differentiation that results in cell enucleation.  
Caspase-14 expression is mainly believed to occur in the epidermis, however may 
also be expressed elsewhere in the body [138, 139].  Caspase-14 is associated with 
human keratinocyte differentiation.  While the mechanism in which caspase-14 is 
contributing to this differentiation is unclear, it is believed to be catalytically active and 
to be responsible for enucleation of keratinocytes in skin barrier formation [133, 140-
142].   
 
Caspases 1 and 3 are associated with skeletal muscle differentiation [143, 144].  
While the activity of both caspases is connected to differentiation, the means in which 
they influence skeletal muscle differentiation are unique.  Caspase-1 degrades 
calpasatin (calpain specific inhibitor) during myoblast differentiation.  Calpain activity is 
required for myoblast fusion into multinucleate fibers.  Caspase-1 is responsible for a 
decrease in calpastatin, allowing calpain activation, resulting in calpain degradation of 
proteins to allow for the fusion of myoblasts [143].  Caspase-3 is believed to influence 
skeletal muscle differentiation via a Mammalian Sterile Twenty-like kinase (MST1) 
related mechanism.  One mean for the activation of MST1 is through cleavage by 
capsase-3 [145].  Caspase-3 knockout mice have defective skeletal muscle 
differentiation [132], defects in these myoblasts is restored with active MST1 
transfection [144].  
 
Caspase-3, -9, and -1 are also involved in brain development and neuronal 
differentiation.  Caspase-1 involvement in neuronal differentiation is similar to its role 
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in myoblast differentiation in that its activity is coupled with calpastatin inhibition and 
calpain activity.  Both caspase-1 and calpain are linked to fodrin degradation, a 
process that occurs in the later stages of differentiation [146].  Caspase-3 and -9 are 
also connected to brain development in that they are believed to be associated with 
neuronal differentiation, migration (discussed below), and in cell death [131, 147-153]. 
 
Caspase-3 and -8 activity is implicated in promotion the migration and invasion of 
glioblastoma cells [153].  Caspase-3 activity was found both in areas of necrosis and 
where unrelated to necrosis.  The cells with activated caspase-3 in areas unrelated to 
necrosis showed no signs of apoptosis.  Interestingly, glioblastoma cells treated with 
broad spectrum caspase inhibitors and zDEVD, a caspase 3/7 inhibitor demonstrated 
decreased migration in standard scratch assays.  Furthermore, this caspase activity is 
responsible for the cleavage of gelsolin, a motility associated protein [153].   
 
3.3  Non-apoptotic functions: Compartmentalized caspase activity 
Caspases have various non-apoptotic roles.  The different functions listed above are 
all united in that they involve basal/low levels of active caspases.  The non-apoptotic 
functions considered here involve caspase activity that differs from those already 
considered in that it is believed to be contained and not distributed throughout the cell.   
 
Caspase-3, and caspase-9 are involved in the formation of platelets.  Platelet 
formation via caspase-3 and caspase-9 is similar to the formation of lens fibers in that 
it is believed to involve PARP cleavage and similar to glioblastoma caspase-3 induced 
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migration in that it involves the cleavage of gelsolin [154].  Staining patters of activated 
caspase-3 led the authors to believe that compartmentalized activation of caspases 
resulted in platelet formation.  Caspase-2 is also associated with platelets.  Endothelial 
cells when stimulated with thrombin cleave ROCK in the process of producing 
endothelial microparticles (EMP).  This ROCK cleavage is decreased upon caspase-2 
inhibition suggesting a role for caspase-2 mediated ROCK cleavage in EMP formation 
[155].  EMP formation is associated with the aggregation of platelets [156].  Although 
the localization (ig. compartmentalized) of caspase-2 has not been explored in this 
context, the activation of caspase-3 and -9 is believed to be compartmentalized in the 
formation of platelets.   
 
3.4   Other non-apoptotic functions 
Several non-apoptotic roles of caspases are demonstrated in Drosophila 
melanogaster.  DRONC, a Drosophila caspase and homolog of caspases 2 and 9, 
has non-apoptotic functions.  DRONC and DIAP1 (Drosophila inhibitor of apoptosis 1) 
are connected to border cell migration during Drosophila development though 
interaction of DIAP1 with the Rac pathway [157].  Regulation of this nonapoptotic 
function is through DmIKKε, an antagonist of DIAP [158, 159].  It is suggested that 
DmIKKε is a negative regulator of actin polymerization and a promoter of the 
nonapoptotic functions of DRONC [160].  DmIKKε may not be the only factor 
influencing DRONC and DIAP1’s role in motility.  Factors such as Rac, actin, and 
other actin regulating proteins cannot be ruled out as regulators of these effects [160].  
DRONC is also associated with proliferation of cells in the Drosophila wing disc [161].  
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Cell death results in the compensatory proliferation of cells in the disc.  DRONC has 
been found to increase both proliferation and Wingless expression (also believed to 
contribute to proliferation) [161].   
 
Drosophila caspases DRICE and DRONC activity is also found to be required for 
sperm differentiation.  DRICE, Drosophila caspase-3-like caspase, activation in sperm 
is responsible for apoptosis like remodeling of the cytoplasm, in that the bulk of the 
cytoplasm is removed.  This activation of caspases in sperm differentiation is brought 
about by cytochome-c and DRICE activation occurs in the early steps of sperm 
individualization and is present throughout this process [162, 163].  Furthermore, 
DARK, DRONC’s activating binding adaptor, and HID, a Drosophila death inducer, are 
all required along with DRONC for DRONC activation in sperm individualization [164].  
Given the similarity of Drosophila and human caspases, it will be interesting to see if 
human caspases possess similar non-apoptotic functions.   
 
Similar to DARK’s influence with DRONC in the non-apoptotic functions of Drosophila, 
CD95 is associated with non-apoptotic functions in humans.  CD95 signaling is linked 
to cellular invasion [165] through NF-kB, Erk, and caspase 8.  Erk activation is further 
connected to caspase-like activity in that its activation has been connected to 
association with DED and FADD/caspase-8/c-FLIP signaling [166, 167].  PEA-15 is a 
death effector domain (DED) containing protein that regulates Fas induced apoptosis 
[168, 169].  Interestingly, PEA-15 is also able to influence Erk activity through 
interaction of Erk with its DED [166, 170, 171].  FADD/caspase-8/c-FLIP signaling is 
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involved in the activation of ERK though stimulation with TNF [167].  Moreover, the 
overexpression of any of these components results in further activation of Erk.  It is 
also interesting to note that when stimulated with TNF cells do not need the enzymatic 
activity of caspase-8 for Erk activation [167].   
 
TNFR1 signaling leads to NF-KB activation [172].  Caspase-8 and caspase-10 are 
linked to NF-KB activation through RIP and NIK, and requires the activity of IKK.  The 
DEDs of caspase-8 and -10 are thought to be required for this activation that has anti-
apoptotic ramifications [173].   
 
CD95, FADD, c-FLIP, and caspase-8 are also involved in aspects of immune function 
[174-179].  CD95, FADD, c-FLIP, and caspase-8 are implicated in T-cell proliferation 
and when these components are lacking proliferation is impaired [174, 178, 180, 181].  
Caspase-8 activity is required for NF-KB activation, which is required for both T-cell 
proliferation and activation [182].  c-FLIP has also been connected to activation, NF-
KB activation, and Erk activation in T-cells [183-186].  Furthermore, c-FLIP is also 
involved in the development and maturation of T lymphocytes [183].   
 
Finally, Caspase-11 is also associated with the promotion of motility.  Caspase-11 
though interaction with Aip1 influences cofilin mediated actin depolymerization [187].  
This interaction, with its influence over cofilin is one example of a caspase having 
influence over cytoskeletal dynamics.  Another example is the potential interaction of 
caspase-2 with RhoB in stress fiber dynamics [188].  While the interaction of caspase-
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2 with RhoB is under apoptotic circumstances, the interaction could also have 
relevance under non-apoptotic conditions.  
 
Closing Remarks 
Understanding the non-apoptotic roles of caspases is a growing area of research.  Of 
the 14 human caspases 2, 3, 8, 9, and 11 have been linked to various functions 
including development, T-cell maturation, proliferation, and/or differentiation (reviewed 
in [133, 177, 189]).  Interestingly, caspases 3, 8, and 9 are also essential for 
embryonic development.  Caspases have also been found to have varying expression 
levels in both cancer and normal cell types [190-192].  When this information is taken 
together, it is probable that there are still non-apoptotic roles for caspases that have 
yet to be explored and that these non-apoptotic functions could have important 
ramifications in cancer therapies. 
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Figure 1 
 
Figure 1:  Erk and Calpain Activation.  Pathways of Erk and calpain activation, 
reviewed in section 1.3.  The pathway from EGFR through Ras to Erk and calpain 
activation is well established, however, the pathway of activation from EGFR to MEKK1 
is not known 
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Figure 2 
 
 
 
 
Figure 2:  Activation of caspase-8.  Caspase-8 dimerizes at the DISC and is autoprocessed 
by two cleavage events.  The first cleavage is at the linker region between p18 and p10 
subunits at D374 and D384.  The second cleavage event is at D216 which releases the 
mature caspase-8 tetramer from the DISC into the cytoplasm  [98].   
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Abstract 
Significant caspase-8 activity has been found in normal and certain tumor cells, 
suggesting that caspase-8 possesses an alternative, nonapoptotic function that may 
contribute to tumor progression. In this article, we report that caspase-8 promotes cell 
motility.  In particular, caspase-8 is required for the optimal activation of calpains, Rac 
and lamellipodial assembly. This represents a novel nonapoptotic function of caspase-
8 acting at the intersection of the caspase and calpain proteolytic pathways to 
coordinate cell death vs. cell motility signaling. 
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Introduction 
Caspases are typically known for their role in preventing cells with abnormalities from 
growing and proliferating.  Caspase-8 expression and activation, however, is altered in 
both normal and cancer cancer cells in certain situations.  Of note, breast and 
pancreatic cancers and glioblastomas exhibit significant caspase-8 activity [1-3], 
which could hold unique non-apoptotic properties.    This reveals a potential 
nonapoptotic role of caspase-8 in tumor progression and normal cell biology.   
 
As reviewed in Chapter 1, non-apoptotic roles are emerging for several caspases.  
Prior to this study, DRONC, the Drosophila caspase homolog of caspases 2 and 9, 
was implicated in boarder cell migration via a mechanism involving an interaction of 
DIAP with the Rac pathway [4].  Additionally, CD95 signaling has been implicated in 
the promotion of cellular invasion [5].  Under FasL stimulation, cells resistant to 
caspase-8 induced apoptosis exhibited increased cellular invasion in a NF-kappaB, 
Erk, and caspase-8 mediated mechanism.  Since the publication of this study, 
additional caspases have been implicated in the promotion of cellular migration [6, 7]. 
 
The phenotype of caspase-8 knockout mice and tissue specific caspase-8 knockouts 
demonstrates embryonic lethality due to the inability to assemble a functional 
circulatory system [8, 9] and proper neural tube closure [8], as discussed in the 
Introduction.  The failure of neural tube and circulatory system closure cannot be 
explained by a lack of apoptosis, thus it would not be surprising for caspase-8 to 
possess a non-apoptotic role involving cellular migration.  In this study we 
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demonstrate that caspase-8 regulates cell motility.  Furthermore, calpains, which are 
deeply rooted in the promotion of migration (reviewed in [10]), are implicated in 
caspase-8 promoted migration.  Consequently, we also demonstrate that caspase-8 
also regulates cellular processes dependent upon calpain activity, such as Rac 
activation, assembly of lamellipodia, and the proper execution of cytokinesis.  This 
reveals a potential nonapoptotic role of caspase-8 in both tumor progression and 
normal cellular biology.   
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Materials and Methods 
Cell lines.  Mouse embryo fibroblasts derived from caspase-8-null, caspase-3-null or 
isogenic wild-type control mice were characterized previously [9, 11]. WTNR6 cells 
[12] were provided by Alan Wells (University of Pittsburgh); to generate derivatives 
expressing the cowpox virus-derived caspase-8 inhibitory protein crmA [13], the HA-
tagged crmA gene was retrovirally transduced using the vector MSCV-IRES-puro in 
the gp2+293 cell packaging system (Invitrogen). NB7 cells that were infected with 
empty GFP retrovirus or rescued with human caspase-8 retrovirus [14] were provided 
by J. Lahti (St. Jude’s Research Institute).  MDA-MB231 (American Type Culture 
Collection) were transduced with crmA as described above. Bcl 460 cells were kindly 
provided by Dr Rojanasakul (West Virginia University [15]).  Cells were maintained in 
Dulbecco’s Modified Eagle’s Medium (MEFs, MDA-MB231), Advanced MEM 
(WTNR6), RPMI1640 (NB7), supplemented with 10% fetal bovine serum and 1X 
penicillin-streptomycin-glutamine (Invitrogen).  
 
Cell lines with inducible caspase-8 expression were generated using the Rheoswitch 
system (www.neb.com).  Caspase-8-/- MEFs (W102) were co-electroporated with a 4:1 
ratio of the “Rheoswitch” activator/repressor-expressing plasmid –NEBR-R1: 
pcDNA3.1hyg and colonies were selected in 500 µg/ml hygromycin.  Colonies were 
expanded and screened for expression of the VP16 moiety of the hybrid activator 
protein by Western blotting and for induction of luciferase activity after transient 
transfection of luciferase/pNEBR-X1.   Wild-type mouse caspase-8 cDNAs was 
subcloned into the pNEBR-X1 target plasmid and co-electroporated in a 4:1 ratio with 
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pBABE-puro.  Colonies were selected in 5 µg/ml puromycin and screened for 
caspase-8 expression by Western blotting with the anti-mouse-caspase-8 antibody 
1G12 (Alexis) after induction with the compound RSL1.  A Western blot of the 
induction time course is shown below (figure 1).  The level of caspase-8 expression at 
24 hours of induction was approximately 30-50% of the level in wild-type MEFs (data 
not shown). 
 
Cell motility assays.  Method 1.  Electrical Cell-Substratum Impedance Sensing 
(ECIS).  Cells were plated on the chambers (~1cm2) of a single-electrode ECIS arrays 
(Applied Biophysics, Troy, New York; www.biophysics.com) that were pre-coated with 
fibronectin.  After growing the cells to confluence, equal coverage of the electrodes 
was checked by measuring the initial impedance value (average=1924 ohms for 
caspase-8-/- cells, 2598 for caspase-8+/+ cells).  The cells attached to the small 
electrode disc (0.25mm diameter) were selectively ablated by applying a 4V pulse for 
10 seconds, causing the impedance drop seen at zero hours.  The impedance 
increase due to the surrounding cells migrating back onto the electrode was then 
monitored at 40 kHz frequency over the indicated time course; migration was in the 
presence of 10% serum and was carried out in triplicate chambers with one additional 
“unwounded” chamber serving as a negative control.  Data were exported to Excel for 
calculation of slopes. 
 
Method 2.  Conventional wound-healing. Cells were grown to confluence on 
fibronectin-coated coverslips or 35mm Mattek dishes, serum-starved overnight (0.5% 
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serum) and the monolayer was wounded with a pipet tip; EGF (10 nM) was then 
added.  The wound was photographed at zero time and at the indicated time points 
using vertical and horizontal alignment marks made on the plastic well with a syringe 
needle.  Three wound areas were traced and measured using the Axiovision software, 
averaged and represented here as the percent wound closure.  Alternatively, one hour 
after attachment, a wound was generated, unattached cells were washed off and 
videomicroscopy was performed on the dish which was incubated on a heated stage 
in CO2-independent medium:CCM1 medium (1:1).  In experiments using the 
rheoswitch inducible cell lines, cells were induced for 24 hours in the presence of 500 
nM RSL1 prior to wounding. 
 
Method 3.  Single cell motility assays. Cells were plated onto fibronectin at low density 
for one hour in the absence of serum, re-stimulated with serum and recorded by 
videomicroscopy for 10 hours.  The paths traveled by seven individual cells were 
traced and the total distance traveled by each cell was computed using the Axiovision 
software (interactive measurement module). 
 
Method 4.  Transwell/chemotaxis assays. Cell migration assays were performed with 
modified Boyden chambers, 6.5mm diameter, 8mm pore size (Transwell from Costar 
Corp.) according to the manufacturer’s protocol.  Briefly, after serum starvation of the 
MEF cells they were harvested with trypsin and quenched with Soybean trypsin 
inhibitor (Calbiochem). The lower compartment of the migration chamber was filled 
with 3T3-fibroblast conditioned media and 6x104 cells were suspended in 
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DMEM/10mM Hepes/0.5% BSA/1% penicillin-streptomycin and added to the upper 
compartment of the migration chamber. Migration chambers were incubated for 4 h at 
37˚C in 5% CO2. After removal of stationary cells from the upper side of the 
membrane, migrated cells were fixed in 3.7% paraformaldehyde in PBS and stained 
with 1% crystal violet in 2% ethanol. Membranes were extensively washed, the dye 
eluted with 10% acetic acid and absorbance was measured at 600nm. Results are 
expressed as % migrated cells relative to a control in which total adherent cell 
absorbance was measured. 
 
Method 5.  Fas Ligand stimulated motility.  Motility assays were performed as 
previously mentioned for standard scratch assays or transwell assays with the 
following exceptions:  FASL was incubated with FLAG antibody (Sigma) for 15 
minutes and applied to cells at a concentration of 100ng/mL FASL to stimulate motility 
in the presence of 2% fetal bovine serum (Invitrogen).  
 
Rac activity assays.  Cells were incubated overnight in DME medium with 0.5% fetal 
bovine serum, and detached by trypsinization and neutralized with an equal volume of 
2.5 mg/ml soybean trypsin inhibitor or detached by treatment with Tryple Express 
(Invitrogen) and neutralized by ten-fold dilution in serum-free medium, followed by 
centrifugation. The cells were then resuspended in serum-free DME containing 20 
mg/ml BSA and plated onto a series of 60mm dishes that had been pre-coated with 
20 µg/ml fibronectin (Calbiochem) and blocked with 3% BSA.  At the indicated times, 
cells were scraped into 0.4 ml of cold lysis buffer  (0.5% TritonX100/50 mM Tris pH 
 56
7.5/150 mM NaCl/10% glycerol/10 mM MgCl2 + 1X complete Roche protease 
inhibitors, EDTA-free) and pre-cleared.  Ten µg of bacterially expressed GST-PAK 
(CRIB domain) protein were added and the samples incubated on ice for 1 hr, 
followed by addition of 30 µL of a 50% slurry of glutathione-sepharose (Pharmacia; 
equilibrated in lysis buffer containing 20 mg/ml BSA) and further incubation for one 
hour in the coldroom on a rotation device.  Beads were washed three times in lysis 
buffer and analyzed on Western blots for rac using monoclonal antibodies from BD-
Pharmingen, peroxidase-labeled anti-mouse antibody (Invitrogen) and Pierce West 
Pico chemiluminescence kit. 
 
Immunofluorescence.  Cell grown on coverslips were fixed with cold methanol for 
the tubulin/pericentrin staining or with 4% paraformaldehyde for the cortactin/actin 
staining, followed by five-minute permeabilization with 0.1% TritonX100 for the latter. 
Cells were stained with anti-α-tubulin mouse monoclonal antibody (DM1A) 
(Calbiochem), anti-pericentrin pAb (Covance), anti-cortactin mAb (S. Weed) or with 
GM130, Golgi matrix protein of 130 kDA, antibody (BD Transduction Laboratories) 
followed by Alexa-488 or Alexa-594 labeled secondary antibodies (Pierce) and 
mounting with Vectashield containing DAPI (Vector Labs). Images were collected on a 
Zeiss Axiovert 200M microscope using AxioVision software and imported into 
Photoshop, where individual color intensities and contrast were adjusted for clarity of 
presentation; image intensities are subjectively accurate but non-quantitative.  
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Cellular Adhesion Assay.  Electrical Cell-Substratum Impedance Sensing (ECIS).  
Cells were counted (5x10^5 cells/well) and let attach to the chambers (~1cm2) of a 
ten-electrode ECIS array (Applied Biophysics, Troy, New York; www.biophysics.com) 
that were pre-coated with fibronectin.  Adhesion was done in the absence of serum 
and was observed until a steady impedance value was reached.   As the cells 
attached to the electrodes of the ECIS array, the impedance increased.  The 
impedance was monitored at 40 kHz frequency and was carried out in triplicate 
chamber.  Data were exported to Excel for calculation of slopes. 
 
Cellular Invasion Assay.  Invasion assays were done according to the BD Biocoat 
Matrigel Invasion Chamber guidelines with few exceptions.  Briefly, invasion chabers 
were allowed to warm to room temperature before rehydrating matrigel with 1x 
phosphate buffered saline (PBS) for 2 hours.  5x104 cells/mL were counted.  0.5mL 
(2.5x104 cells) were added to the top chamber of a 24 well plate insert +/- 100ng/mL 
FASL in 0.5% serum containing media and allowed to invade for 6-72 hours toward 
serum and FASL containing media.   
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Results 
Caspase-8 regulates cell motility.  We assayed mouse embryo fibroblasts (MEFs) 
obtained from caspase-8-knockout mice or wild type MEFs [9] for motility utilizing an 
Electrical Cell-Substratum Impedance Sensing (ECIS) instrument [16].  Caspase-8 
deficient cells exhibited decreased motility (figure 2A).  These results were mirrored in 
conventional wound-healing assays (figure 2B).  The viral caspase-1/8 inhibitor 
protein crmA [13] was also expressed in the wild-type MEFs, MDA-MB231 mammary 
carcinoma cells, and WTNR6 fibroblasts.  CrmA expression inhibited motility via 
transwell chemotaxis and via standard wound healing assay analysis (figure 2C and 
2D). Caspase-8 expression was also re-established in an inducible manner in 
caspase-8 knockout MEFs.  Similarly to wild type MEFS, induction of caspase-8 
restored cellular migration to knockout MEFs (figure 2E).  The addition of crmA, and 
analysis of inducible caspase-8 re-expression confirm that a decrease in cellular 
migration was not an irreversible defect of the caspase-8 knockout cell lines.  
Furthermore, caspase-3 did not stimulate cell motility (figure 2F).  This result suggests 
that caspase-8 may act directly to promote cell motility, rather than through its 
downstream effector caspase-3.  Additional downstream caspases cannot be 
excluded. 
 
Because mammary carcinomas exhibited decreased transwell migration upon crmA 
expression, other tumor lines were examined for caspase-8 promoted cell migration.  
Similar results were obtained in NB7 neuroblastoma cells [14] reconstituted with 
caspase-8 and in MDA-MB-231 mammary carcinoma cells made to express crmA 
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(figure 2G, H, I).   Caspase-8’s promotion of cellular migration is thus not limited to 
normal cell biology; it is also an important factor in cancer cell biology and tumor 
progression.   
 
Activation of caspase-8 by FASL promotes invasion (through NF-kB, Erk, and 
caspase 8 [5]).   Consistent with the results of Barnhart et al. [5] we found that FASL 
stimulated cellular invasion and that caspase-8 was important for this process (Figure 
3 A,B,C).  These results suggest that caspase-8 expression in tumors resistant to 
caspase-8 induced apoptosis may actually promote tumor metastasis through 
increased cellular migration and invasion.   
 
Caspase-8 affects cellular processes downstream of calpain activation.  Work 
from our laboratory demonstrated that caspase-8 is important for the activation of 
calpain activity by EGF [17].  To confirm that caspase-8 regulates the calpain 
pathway, we examined several calpain-dependent processes for caspase-8-
dependence: Rac activation, lamellipodial assembly, cell adhesion and proper cellular 
division [10, 18-22].  Caspase-8-/- cells exhibited a. decreased levels of Rac activation 
when compared to control cells (figure 4); b. fewer lamellipodia than their caspase-8 
expressing counterparts (figure 5A,B); c. decreased cell adhesion, measured by ECIS 
(figure 5C); d. more multinucleate cells than their caspase-8 expressing counterparts 
(figure 5D).   Calpains are also associated with cell polarity, however this point is only 
recently found in the literature and is yet to be well established [23].  Interestingly, 
capase-8 did not influence cell polarity (figure 5E).    
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Caspase-8 promotes Erk activation.  We hypothesized that the connection of 
caspase 8 and calpain in the promotion of migration occurs through the coordination 
of the EGFRÆMAPK/Erk signaling pathway.  Both calpains and caspase-8 have been 
liked to signaling pathways containing Erk [5, 12, 24-27].  Erk itself is associated with 
the phosphorylation of calpain and its activation [12] upon stimulation from EGFR.   
Consistent with this, EGF stimulation of cells lacking caspase-8 demonstrated 
attenuated activation (Figure 6).   
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Discussion and Future Studies 
Caspase-8, an initiator caspase in the process of apoptosis has been suggested to 
have roles in normal cell biology based upon its requirement for proper development 
of mice and other developmental requirements in tissue specific knockout animals [8, 
9].  In this study we have shown that Caspase-8 is an important element in the 
promotion of cell migration.  Moreover, caspase-8 is also required for enhanced 
cellular adhesion, invasion, lamellipodia projection, and proper cytokinesis.  A 
comparison of caspase-8 expressing MEF against knockout MEF demonstrated an 
increased Rac activation upon cellular adhesion in cells expressing caspase-8 (Figure 
4).   
 
Additional data from our laboratory has shown that caspase-8 also contributes to 
calpain activation [17].  This data paired with caspase-8’s ability to promote Erk 
activation makes Erk activation pathways an interesting target for caspase-8’s 
promotion of cell migration.  As stated in the Introduction (Chapter 1) calpain is an 
important mediator of cell migration (lamellipodia projection, cellular adhesion 
dynamics etc) and that Erk activation promotes calpain activity.   
 
Caspase-8 has previously been linked to Erk activation in the context of 
CD95/FADD/caspase-8/c-FLIP, as reviewed in the introduction.  CD95 (Fas/Apo-1) is 
a death receptor responsible for the formation of the death inducing signaling complex 
(DISC) [28] to promote apoptosis.  Directly related to this study, CD95 signaling is 
nonapoptotically associated with invasion and motility through NF-kappaB, Erk and 
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caspase-8 signaling [5] upon stimulation by FasL.  In our model, motility and invasion 
are also influenced by caspase-8 when stimulated/attracted by EGF, a response that 
is also mirrored with FasL stimulation.   
 
While initially believed to be contradictory to our work, loss of caspase-8 has been 
shown to increase metastasis in neuroblastoma cells [29].  Neuroblastoma cells often 
eliminate caspase-8 expression by hypermethylating the caspase-8 promoter [14], 
making it an ideal system in which to study the effects of caspase-8.  Re-expression of 
caspase-8 is shown to restore motility in neuroblastoma cells (Figure 2H).  
Additionally, caspase-8 promotes cellular invasion (Figure 3 [5]).  While our results 
would be believed to aid in metastasis, not inhibit it, the results of Stupack et al 
examine caspase-8 in an apoptotic context.  Re-expression of caspase-8 can, 
paradoxically, suppress metastasis by conferring anoikis-sensitivity [29, 30].   
However, most metastatic tumor cells express caspase-8 but are, by definition, 
resistant to anoikis.  Thus, in most human tumors, the presence or absence of 
caspase-8 is not the major determinant of anoikis-sensitivity. 
 
Relevant to this study, it is important to note that the use of viral inhibitor crmA [13] 
should not be interpreted as solely blocking the catalytic activity of caspase-8.  CrmA 
also binds to full length caspase-8 and thus able to block the catalytic activity of full 
length caspase-8 as well as block potential protein;protein interactions [31].  Should 
the catalytic activity of caspase-8 be required for the promotion of calpain activity, as 
we predict it is, crmA would be able to block this catalytic activity.     Using Rheoswitch 
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inducible MEF cells, we attempted to determine if the catalytic activity of caspase-8 
was required for the promotion of cell migration and caplain activity, however, these 
results were inconclusive.   
 
As stated, we hypothesize that the connection of caspase 8 and calpain in the 
promotion of migration occurs through the coordination of the EGFRÆMAPK/Erk 
signaling pathway.  In this model, Erk can be activated through the well established 
growth factor receptorÆRasÆRafÆMek pathway (reviewed [32, 33]) or through 
interaction of EGFR with FAK signaling to MEKK1 [34].  MEKK1 then activates Erk 
(Chapter 1, Figure 1) leading to the subsequent calpain activation.  Additionally, 
calpain could be activated in a MEKK1 cleavage dependent manner.    Supporting this 
hypothesis, caspase-8 and -3 can activate MEKK1 by direct cleavage ([35] and [27, 
36] respectively).  The dependence of caspase-8s proteolytic activity in these 
processes has yet to be addressed.  Our current model predicts that the catalytic 
activity of caspase-8 is needed for calpain activity through the MEKK1 pathway.  
Potential pathways are overviewed in Figure 7.  Currently, we are in the process of 
generating MEKK1 inducible Rheoswitch cells that express either wild type MEKK1 or 
the caspase-8 uncleavable mutant [35] of MEKK1 in MEKK1 knockout MEF [37].  
These cells will initially be examined for their ability to promote cell migration, calpain 
activation/phosphorylation, and Erk activation.  While we have yet to make a direct 
connection in our model between caspase-8 with MEKK1 signaling to calpain, this 
remains a focus of our laboratory.   
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Figure 1 
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Figure 2 
 
 
 
 
Figure 2.  Caspase-8 promotes cell motility. (A).  ECIS analysis of caspase-8-/- vs. caspase-
8+/+ mouse embryo fibroblasts (MEFs). (left-hand panel):  Impedance vs. time plot.  (right-hand 
panel): Graphic representation of slopes calculated from the linear part of the graphs in the 
ECIS tracing (after subtraction of slopes measured in “unwounded” wells).  (B). Conventional 
wound healing assay, comparing caspase-8-/- vs. caspase-8+/+ MEFs. 
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Figure 2. (C). Directed migration/chemotaxis assay, comparing MDA MB231 cells +/- CrmA, 
normalized for total number of adherent cells (experiment done by AD).  (D) CrmA inhibits 
motility in WTNR6 cells (conventional wound healing assay upper) and in MEFs (conventional 
wound-healing assay lower). The white lines indicate the position of the original wound border 
in each photograph.   
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Figure 2.  Caspase-8, but not caspase-3 promotes cell migration. (E) Inducible re-
expression of caspase-8 stimulates motility in caspase-8-null MEFs (p<0.001); the right-hand 
panel shows a control cell line with the rheoswitch control proteins but without caspase-8.  (F) 
Caspase-3 does not promote cell motility. Caspase-3-/- and caspase-3+/+ MEFs were assayed 
for wound healing as in part B.   
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Figure 2.  Caspase-8 promotes cell motility in tumor cells.  (G). ECIS analysis, comparing 
the caspase-8-null neuroblastoma cell line NB7 (“NB7-“) vs. the caspase-8-rescued derivative 
cell line (“NB7+”); a graphic representation of slopes calculated from the linear part of ECIS 
curves (five samples for NB7-, six samples for NB7+).  (H) Single-cell motility assay, 
comparing NB7 cells vs. NB7+caspase-8 cells. The plot shows the distance (not direction) 
migrated by individual cells.   
G 
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Figure 2.  (I) Conventional wound healing assay, comparing the mammary carcinoma cell line 
MDA-MB-231 with empty vector vs. crmA. Cells migrating (four hours) into three areas of fixed 
size and fixed distance from original wound border were counted, averaged, and represented 
graphically. 
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 Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Caspase-8 and FASL promote motility and invasion.  (A) Caspase-8 promotes 
cellular invasion (upper graph), FASL stimulates invasion similarly to serum.  
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Figure 3.  (B) Caspase-8 promotes invasion and transwell migration (Fig 2C) in MDA-MB231 
cells.  
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Figure 3. (C) FASL addition in these cells (MDA-MB231) also promotes cell migration (upper- 
caspase-8 +/- FASL in transwell migration – lower- +/- caspase-8 +/- FASL transwell 
migration) 
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Figure 4 
 
 
 
 
Figure 4.  Caspase-8 promotes Rac activity. Caspase-8-/- or caspase-8+/+ MEFs were 
assayed at the indicated times after attachment to fibronectin for activated or total rac; the 
amido black stained filter shows equal loading (the BSA band arises from the carrier protein 
used in the cell attachment-incubation buffer; the zero time sample is free of BSA because 
cells were immediately lysed after trypsinization.) Experiments done by SF and BH 
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Figure 5   
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Figure 5. Caspase-8 affects cellular processes downstream of calpain activation: 
lamellipodial assembly, cell adhesion and normal nuclear segregation. (A).  Caspase-8 
promotes the accumulation of lamellipodia.  (upper two rows).  MCF10a cells with or without 
crmA were plated at low density in media containing EGF, fixed and stained with antibodies 
against the lamellipodia marker cortactin (green), rhodamine-phalloidin (red) and DAPI (blue).  
(lower row).  The “attachment-control” MEFs that were assayed for chemotactic migration in 
figure 1C were stained with crystal-violet and photographed. Frequencies of lamellipodia were 
scored and represented graphically (the phase images were used to generate the MEF 
graph). (p-value for MEFs:  p<0.003, MCF10a:  <0.001). (B). Caspase-8 promotes the 
accumulation of lamellipodia:  caspase-8-inducible cell lines.   
A 
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Figure 5:  (C).  Caspase-8 promotes cell adhesion to matrix in MEF cells and NB7 cells. 
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Figure 5:  (D) Caspase-8-deficiency induces an elevated frequency of multinucleated and 
multicentrosomal cells. Caspase-8-/- or caspase-8+/+ MEFs were fixed and stained with anti-α-
tubulin (red), anti-pericentrin (green) and DAPI (blue). The frequencies of nonmitotic cells with 
greater than one nucleus were scored and depicted graphically (p<.0001). Examples of a 
multinucleate cell and a normal cell are shown below. Note that multinucleate cells often had 
>2 centrosomes. 
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Figure 5: (E). Cell polarity was not altered by the lack of caspase 8.  MEFs were fixed and 
stained with rhodamine phalloidin (red), with GM130 golgi stain (green), and DAPI (blue).  
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Figure 6 
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Figure 6.  Caspase-8 promotes Erk activation.  Cells were serum starved and treated with 
10nM EGF to stimulate Erk activation.  Graph represents the ratios of active to total Erk based 
upon densitometry of western blots of the Erk activation lysates. 
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Figure 7 
 
 
 
 
 
 
 
 
 
Figure 7.  Proposed pathway for how caspase-8 is influencing cellular motility via an 
MEKK1 activation dependent mechanism that results in subsequent Erk and calpain 
activation.   
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Chapter 3 
Pro-Caspase-8 promotes cellular migration and 
adhesion through interaction with the p85 
subunit of PI3K 
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Abstract 
Cell migration plays an important role in tumor cell invasion and metastasis.  We 
reported that caspase-8 contributes to cell migration and adhesion, a novel 
nonapoptotic function of an established apoptotic factor. In this study, we report that 
pro-caspase-8 is capable of restoring cell migration/adhesion to caspase-8-null cells, 
establishing the first biological function of a pro-caspase. The catalytic activity of 
caspase-8 was not required for cell motility. Stimulation of motility with epidermal 
growth factor induced the phosphorylation of caspase-8 on tyrosine-380 and the 
interaction of caspase-8 with the p85α subunit of phosphatidylinositol 3-kinase. 
Tyrosine-380 was required for the restoration of cell motility and cell adhesion in 
caspase-8-null cells, demonstrating the importance of the caspase-8–p85 interaction 
for these nonapoptotic functions. These results suggest that caspase-8 
phosphorylation converts it from a proapoptotic factor to a cell motility factor that, 
through tyrosine-380, interacts with p85, an established cell migration component.  
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Introduction 
In chapter 2, we reported that caspase-8 promotes cell migration, adhesion, invasion, 
and Rac activation in normal and tumor cell lines [1], processes important in tumor cell 
metastasis [2].  Certain tumors, such as neuroblastoma and small-cell lung cancer, 
involve the loss of caspase-8 expression [3, 4], but many tumor types retain and often 
over-express caspase-8 (Figure 1). Thus, caspase-8 may contribute to metastasis in 
cell types that are resistant to apoptosis due to alterations in numerous genes, other 
than caspase-8.  This mechanism could have important ramifications for cancer 
therapy.   
 
Recently, caspase-8 has been shown to be phosphorylated by src in a manner that 
prevents its autocleavage during apoptosis [5].  The site of src phosphorylation is at 
tyrosine residue 380, which is located in the caspase-8 linker region spanning amino 
acids 374-384 (Figure 8).  In the proapoptotic processing of caspase-8 this is the first 
sequence of caspase-8 that is cleaved in its autoactivation [6].  Thus, the only form in 
which caspase-8 would be phosphorylated would be as a full length procaspase.  Our 
laboratory hypothesized that the phorphorylated form of pro-caspase-8 might interact 
with signaling proteins involved in cell migration, a major focus of this chapter.   
 
As reviewed in chapter 1, one important cell migration factor that interacts with 
tyrosine phosphorylated partners is phosphatidylinositol 3-kinase (PI3K).  P85, the 
regulatory subunit of PI3K, is affected by the binding of tyrosine phosphorylated 
proteins to its SH2 domains, as well as by src-mediated phosphorylation [7].  The p85 
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subunit is able to interact with many proteins involved with the promotion of migration, 
such as EGFR, RhoGAP1, Ras, FAK, c-Src, [8-12].  p85 has also been shown to 
interact with Rac and cdc42 and potentially contribute to cytoskeletal dynamics [13-
15].  Although PI3K activity is known to activate Rac by promoting PIP3 and 
stimulating Rac-GEF activity, the direct interaction of Rac with p85 might play an 
additional role in Rac regulation, which has not been addressed.  The phosphorylation 
of caspase-8 at Y380, within the sequence YELM, makes it a candidate for SH2 
domain interaction.  
 
Procaspase-8 retains catalytic activity [16] and may be able to promote migration 
through cleavage of various unidentified substrates; alternatively it may interact with 
SH2 domains of migration promoting proteins, such as PI3K, via phosphorylated Y380 
to promote cell migration.  The phosphorylation of caspase-8 also supplies an 
attractive switch mechanism between its promigratory, non-apoptotic functions, and its 
role in apoptosis.  
 
In this study, we show that Y380-phosphorylated pro-caspase-8 interacts directly with 
the p85 subunit of PI3K, promoting cell adhesion and motility.   
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Experimental Procedures 
Cell lines.  NB7 cells were obtained and cultured as described previously (2). Stable 
derivatives expressing caspase-8 mutants were constructed by packaging the 
appropriate retrovirus construct in the vector pBABE-puro in gp2+293 cells in the 
presence of pAmpho (Invitrogen), infection of viral stock, selection with 0.5 µg/mL 
puromycin, and western blotting of mixed populations; similar expression levels were 
obtained for all constructs used in this study (data not shown).  MTLN3s were kindly 
provided by Dr Scott Weed.  A431 epidermal carcinoma cells were obtained from 
American Type Culture Collection and maintained in MEM containing 10% fetal 
bovine serum, penicillin, streptomycin, and glutamine. 
 
DNA constructs, transfections, and pull downs.  All caspase-8 constructs were 
made by PCR using catalytically inactive caspase-8 (C360A) template kindly provided 
by G. Salvesen (Burnham Institute).  Mutations were made by the use of the 
Stratagene Quick-Change mutagenesis system, according to manufacturer’s 
instructions, in the vector pNEBRX1 (New England Biolabs) and mutant constructs 
were sequenced, prior to being subcloned into the BamHI-SalI site of pBABE-puro.  
To create S-tag constructs, a double-stranded oligonucleotide encoding the S-tag 
sequence (forward:  GATCCAAAGAAACCGCTGCTGCGAAATTTGAACGCCAGCA 
CATGGACTCGTAGGC; reverse: GGCCGCCTACGAGTCCATGTGCTGGCGTTCA 
AATTTCGCAGCAGCGGTTTCTTTG) was synthesized and three-way ligated with a 
HindIII-BamHI PCR fragment of caspase-8 and pcDNA3.1 linearized with HindIII and 
NotI.  Caspase-8-S-tag/pBABE-puro retroviruses were constructed by subcloning the 
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PmeI-PmeI fragments from the pcDNA3.1 constructs into pBABE-puro that was 
linearized with SnaBI. 
 
A431 cells were serum-starved in Dulbecco’s Modified Eagle’s Medium containing 
penicillin, streptomycin and glutamine overnight.  After treatment for four minutes with 
200 ng/ml EGF (Calbiochem), cells were lysed by scraping in in 25mM Tris 
pH7.6/150mM NaCl/25mM NaF/1% TritonX100/1 mM sodium orthovanadate/1X 
Roche complete protease inhibitor cocktail.  Sodium deoxycholate was added to the 
lysate to give 0.5 % final concentration, and, after pre-clearing at 13,200 rpm for 12 
minutes, SDS was added to 0.1% final concentration. For S-tag pulldown 
experiments, S-protein agarose bead suspension that had been pre-equilibrated in 
lysis buffer containing 10mg/ml bovine serum albumin and 10mg/ml ovalbumin and 
washed three times prior to use, were added to the lysates.  After incubation with the 
beads at 4 degrees for 1.5 hours with rotation and three washes, samples were boiled 
in SDS sample buffer and analyzed on western blots. Antibodies for western blotting 
were from the following sources:  caspase-8 (mAb 3-1-9):  BD Biosciences; HA (mAb 
HA.11):  Covance, Inc.;  p85 (pAbs 06-195 and 06-496): Upstate Biotechnology. 
 
Rac activation assay.  Cells were incubated overnight in RPMI with 0.5% FBS, 
detached by treatment with TrypLe Express (Invitrogen) and neutralized by 10-fold 
dilution in serum-free medium, followed by centrifugation. The cells were then 
resuspended in serum-free RPMI containing 3% BSA and plated onto a series of 6 
well plates precoated with 15 µg/mL fibronectin (Calbiochem) and blocked with 3% 
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BSA. At the indicated times, cells were scraped into 0.6 mL cold lysis buffer [25mM 
HEPES, 150mM NaCl, 10mM MgCl2, 5% glycerol, 1% Igepal + complete Roche 
protease inhibitors, EDTA-free] and precleared. Ten micrograms of bacterially 
expressed GST-PAK (CRIB domain) protein were added and the samples were 
incubated on ice for 1 hour, followed by addition of 30 µL of a 50% slurry of 
glutathione-Sepharose (Pharmacia, Piscataway, NJ; equilibrated in lysis buffer) and 
further incubation for 1 hour in the cold room on a rotation device. Beads were 
washed thrice in lysis buffer and analyzed on Western blots for Rac using monoclonal 
antibodies (mAb) from BD PharMingen, peroxidase-labeled antimouse antibody 
(Zymed), and Pierce West Pico chemiluminescence kit (Pierce, Rockford, IL). 
 
Adhesion and motility assays. Adhesion measurements using electrical cell 
substrate impedance sensing (ECIS) and motility measurements using single-cell 
motility were done as described previously ([1] chapter 2).   Summarized briefly: 
(Single cell motility assay):  Cells were plated onto fibronectin coated dishes at low 
density for 2 hours in the absence of serum, stimulated with 10%serum containing 
CO2 independent media (Invitrogen), and recorded by videomicroscopy for 8 hours. 
The paths traveled by individual cells were traced and the total distance traveled by 
each cell was computed using the Axiovision software (interactive measurement 
module) and depicted radially using Excel. 
 (Electrical cell-substratum impedance sensing):  Eight well ten-electrode electrical 
cell-substratum impedance sensing (ECIS) arrays (Applied Biophysics, Troy, NY; 
www.biophysics.com) were pre-coated with 15 µg/mL fibronectin. Cells were the 
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trypsinized, spun down, and resuspended in serum free media.  1x105 cells were 
applied per well.  As cells attach to the array, the impedance increases due to the 
cells attaching and spreading onto the electrode.  Adhesion was then monitored at 45 
kHz frequency over the indicated time course; adhesion was carried out in duplicate or 
triplicate. Data were exported to Excel for the calculation of slopes. 
 
 Akt and EGFR phosphorylation assays.  NB7 cells +/- caspase 8 were serum-
starved overnight (0.5% serum) at ~75% confluence. Cells were then treated with 
10ng/mL EGF for 0, 2.5, 5, 10, 35, and 60 minutes, washed in cold PBS and lysed in 
SDS sample buffer.  Lysates were analyzed on parallel western blots for phospho-Akt 
(Cell Signaling rabbit polyclonal Phosphoserine-473-Akt) and total Akt (Cell Signaling 
Akt pAb) or with phospho-EGFR (Zymed) or total EGFR (BD Transduction Labs).  
Scans were quantitated by the use of Image J software. 
 
Recombinant protein generation and in-vitro interactions.  S-tag caspase-8 was 
generated in pET29a and GST-p85 in pGEX.  Recombinant protein isolation was 
done as described previously [17].  Briefly,  overnight cultures of bacteriaprep were 
inoculated into 500mL of pre-warmed LB, incubated for two hours and 0.15mM IPTG 
added and incubated for an additional 2 hours.  Bacteria is then isolated, resuspended 
in protease inhibitor containing PBS and lysed in 10 µM DTT, 1% Triton-X 100, and 
1mg/mL lysozyme, sonicated and then pelleted.  The supernatant is then incubated s-
tag beads or with glutathione sepharose, that was prequillibrated with PBS, for two 
hours at 4°C.  Beads were then isolated, washed and resuspended in inhibitor 
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containing PBS in the case of caspase-8 or eluted with 20mM glutathione and 
dialyzed against PBS in the case of GST-p85. 
 
Caspase-8 was phosphorylated by mixing beads with src kinase buffer (25mM 
HEPES pH7.5, 0.01% Brij35, 0.03% beta-mercaptoethanol, and 10mM MgCl2 +/- 50 
µM ATP + Pierce protease inhibitor cocktail) and 0.5 µg of active Src (Upstate) for 30 
min on a wheel at 37°C.  Beads were then washed in 1X interaction buffer (25mM Tris 
pH8, 150mM NaCl, 0.1% Triton-X 100, 10% glycerol, 1mg/mL BSA, and 0.5mM DTT) 
then mixed with GST-p85 or GST (5 or 10µg) for 3 hours at 4°C.  Beads were then 
isolated, washed with interaction buffer and lysed in 2x LSB+10% beta-
mercaptoethanol and western blot probing for p85 N-terminal SH2 domain (Upstate).   
 
Immunofluorescence:  Cell grown on coverslips were treated with 100nM EGF or 
100nM Rhodamine labeled EGF and then fixed with 4% paraformaldehyde in PBS.  
Cells were then permeabilization with 0.1% TritonX100 for five-minutes.  Cells were 
stained with anti-HA mouse monoclonal antibody (Covance), Primary antibody 
incubation was followed by Alexa-488 (Pierce) and rhodamine phalloidin when R-EGF 
was not used.  Coverslips were then mounted with Vectashield containing DAPI 
(Vector Labs). Images were collected on a Zeiss Axiovert 200M microscope using 
AxioVision software.   
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Results  
Caspase-8 enhancement of cell adhesion/motility is dependent on 
tyrosine-380, but independent of catalytic activity or autoproteolytic 
processing.   Chapter 2 demonstrated that caspase-8 promoted EGF stimulated cell 
migration and adhesion in MEF as well as in other normal and cancer cell models [1].  
The lack of caspase-8 activation/cleavage products suggested that pro-caspase-8 
might be performing these functions (data not shown).  An uncleavable mutant of 
caspase-8 (DA, D374A/D384A [6]) was examined for its effects on both cellular 
adhesion and migration (Figure 2).  The caspase-8 DA mutant was expressed in 
neuroblastoma cells and was found to promote both adhesion and migration as 
effectively as did wild-type caspase-8 (Chapter 2).  A catalytically inactive mutant, 
C360A, also promoted cellular adhesion and migration (Figure 2).  These results 
indicated that caspase-8 performs these functions independently of catalytic activity 
and auto-cleavage.   
 
Src phosphorylates caspase-8 on Y380 and prevents its proapoptotic processing [5].  
Accordingly, we confirmed that EGF stimulation results in the phosphorylation of 
caspase-8 (Figure 3B [5]).  Since Y380 phosphorylated caspase-8 is only present in 
procaspase-8, non-phosphorylated mutants (Y380F) were tested in the context of both 
uncleavable and catalytically inactive caspase-8.  When Y380 was mutated to 
phenylalanine, caspase-8 failed to promote both cellular adhesion and migration 
indicating that this residue is crucial for the promotion of its non-apoptotic functions.  
These results suggest that caspase-8 may interact with other signaling proteins 
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through phospho-Y380 to elicit its effects, being that the promotion of adhesion and 
migration is independent of catalytic activity. 
 
Caspase-8 interacts with the p85 subunit of PI3K.   Phosphorylation of 
caspase-8 on Y380 warranted the investigation of potential SH2 domain interactions.  
To test potential interactions with SH2 domain proteins, a SH2 domain array 
(Panomics) was screened with a phosphorylated peptide spanning the Y380 
sequence (Figure 3A, experiment performed by SF).  Several proteins were detected 
via this approach but few failed to show an interaction in co-transfection experiments 
(supplemental figure 2 of [18]).  Of particular interest was the C-terminal SH2 domain 
of the p85 subunit of PI3K because interaction with p85/PI3K could explain the 
promigratory/adhesion results of procaspase-8. 
 
To determine an optimal phosphorylation time for caspase-8 upon EGF stimulation, 
caspase-8 isolation (s-tagged C360A caspase-8 construct pull down) was analyzed in 
the context of stable A431, epidermal carcinoma, cells.  Five minutes of EGF 
stimulation was optimal for caspase-8 phosphorylation (Figure 3B).   
 
To further examine a caspase-8 p85 interaction, A431 cells were subjected to s-
tagged C360A caspase-8 pull downs after EGF stimulation.  A time course of EGF 
stimulation shows that caspase-8 interacts with the p85 subunit of PI3K (Figure 3C).  
This interaction was also verified via endogenous caspase-8 immunoprecipitation by 
p85 (Senft et al Figure 3D [18]).  Moreover, the in-vitro phosphorylation of 
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recombinant caspase-8 by src followed by incubation with recombinant p85 indicates 
that phospho-caspase-8 interacts directly with p85, as implied by the Panomics SH2 
array (Figure 3D).   
 
The caspase-8–p85 interaction affects Rac activation. The activation of Rac 
following cell-matrix adhesion was partially dependent on caspase-8 (Chapter 2 [1]).  
The importance of Y380 in both cellular adhesion and migration warranted the 
examination of its role in Rac activation.  Upon cellular adhesion, neuroblastoma 
cells expressing Y380 or F380 caspase-8, were analyzed for Rac activation.  Y380 
caspase-8 promoted Rac activation (Figure 4A) more efficiently than F380 caspase-
8, supporting the results in Figure 2.  One potential mechanism for the activation of 
Rac through p85 is the stimulation of PI3K activity.  Utilizing phosphorylation of Akt 
on serine-473, an indicator of PI3K activity, Akt phosphorylation was not, affected by 
caspase-8 after EGF stimulation (Fig. 4B) or serum re-addition (data not shown). It is 
therefore more likely that caspase-8 affects Rac activation mediated by p85 through 
an alternative mechanism that remains to be elucidated (see Discussion). 
 
Caspase-8 at the cell periphery, a potential EGFR signaling complex.  Caspase-8 
could also interact with p85 in a complex involving EGFR.  Colocalization imaging was 
done for caspase-8 and EGFR in A431 cells that were made to express low levels of 
HA-caspase-8 (C360A).  These images showed relocalization of a fraction caspase-8 
from a perinuclear staining pattern to membrane ruffles after EGF treatment (Fig 5A).  
To further examine this phenomenon HA-caspase-8 was examined in MTLN3 cells 
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due to their ready formation of lamellipodia upon EGF stimulation.  MTLN3 cells again 
showed a striking relocalization of caspase-8 to membrane ruffles after EGF treatment 
(Fig 5B).  Due to the colocalization of caspase-8 with rhodamine labeled EGF, it is 
possible that caspase-8 interacts with protein complexes along with EGFR, or with 
EGFR directly to influence p85 and potention Rac activation.  EGFR phosphorylation 
on Y1086 was not influenced by the expression of caspase-8 (Fig 5C), nor was 
phosphorylation of Y1068 (data not shown) making it unlikely that capase-8 is 
affecting EGFR signaling/activation.  While these are preliminary experiments, 
caspase-8 s-tag pull downs of EGFR were variable, but occasionally showed co-
precipitation, warranting another look at this potential interaction.     
 
Caspase-8 D302 influences cellular adhesion and migration.  Two additional 
forms of caspase-8 were examined to determine if they influenced caspase-8’s ability 
to promote cell migration and/or cellular adhesion.  A single nucleotide polymorphism 
(SNP), D285H, is associated with reduced susceptibility to breast, lung, gastric, 
colorectal, and cervical cancers [19-21].  This polymorphism did not affect cell 
adhesion or cell motility (Fig 6).  We also examined D302H because this aspartate 
residue is adjacent to a p85 binding consensus sequence (YXXMD), suggesting that 
additional p85 binding sites on caspase-8 may exist (see [18] Figure 3B Y380F 293T 
analysis).  Mutation of the aspartate reside (D302H) diminished caspase-8’s ability to 
promote cellular motility and adhesion (Fig 7).  These data suggested that the 
298YXXM301 motif may be able to bind p85, an experiment that has yet to be 
addressed.   
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Discussion and Future Studies 
Caspase-8 promoted cell migration (Chapter 2).  This study expands upon this 
phenomenon demonstrating that both pro-caspase-8 and a catalytic-inactive mutant of 
caspase-8 promoted cell migration and adhesion.  Importantly, the Y380 residue of 
caspase-8 was required for these processes, a residue that is lost upon the first 
autocleavage event of caspase-8 in apoptosis [6].   
 
EGF treatment induces the phosphorylation of caspase-8 on Y380, possibly mediated 
by c-src [5].  We have shown that this phosphorylation is crucial for caspase-8 
interaction with the p85 regulatory subunit of PI3K.  Initial screening of phosphorylated 
caspase-8 with a Panomics SH2 array suggested direct interaction of caspase-8 with 
other proteins in a phosphorylation SH2 domain dependent manner.  This interaction 
led us to believe that caspase-8 could be involved in a signaling complex to promote 
cellular adhesion and motility.  The C-terminal SH2 domain of p85 interacted with 
Y380-phosphorylated caspase-8 [18].  In vitro interaction studies confirmed that 
phospho-caspase-8 was interacting directly with p85.  A subsequent publication 
showed an interaction of phosphorylated caspase-8 with c-src in vitro, a result that is 
not inconsistent with ours’ [22].  This report confirmed that the catalytic activity of 
caspase-8 was not required for cell migration and the Y380 residue was required.   
 
We also examined the role of a caspase-8 D285H in cell migration.  D285H is a SNP 
of caspase-8 that is associated with decreased incidence of several cancers, did not 
influence cell migration/adhesion.     Interestingly, a six-nucleotide polymorphic variant 
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has been found in the promoter region of caspase-8 [21].  This polymorphism 
decreases caspase-8 expression and also results in decreased cancer incidence.  
This paired with the maintenance of caspase-8 in many tumors indicates that 
caspase-8 may contribute to tumor progression through its interaction with the p85 
subunit of PI3K. 
 
A third paper dealing with caspase-8 and the promotion of adhesion agrees that 
caspase-8 does not require catalytic activity to promote cellular adhesion [23].  They 
examined caspase-8’s ability to interact with src at the cell periphery.  They attributed 
this localization to an interaction of src with the death effector domains of caspase-8.  
We have not examined the role of the death effector domains of caspase-8 in cellular 
adhesion and migration, but we noted that, in contrast with Finlay et al [23], the DED 
domains of caspase-8 were found to aggregate and mislocalize [24].  Also, the DED 
domains alone were found to induce cell senescence, rendering any effects on 
adhesion and motility difficult to interpret [25].   
 
Caspase-8’s ability to interact with p85 and yet activate Erk and Rac leads to the 
inquiry of other proteins involved in a complex with caspase-8.  This question is one 
being examined by our lab presently.  The caspase-8:p85 complex could interact 
directly with Rac to influence its activity or could interact with other proteins to convey 
this promotion [26].  Further in-vitro interactions of caspase-8, p85 and Rac are being 
explored.  Proteomic analysis for novel caspase-8 interactions are being conducted, 
using stable cell lines expressing caspase-8-FLAG-S-tag constructs and sequential 
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purification on FLAG and S-protein affinity resins.  Thus far ANT2 (Adenine Nucleotide 
Translocase) has been isolated as an interactor.  We anticipate that caspase-8 and 
ANT2, which is a mitochondrial co-factor for Bax activation [27, 28], contributes to 
apoptosis but is unlikely to be involved in mechanisms addressed here.   
 
The interaction of phosphorylated caspase-8 with p85 provides one mechanism for 
the effects of caspase-8 on cell adhesion, migration, and Rac activation. It is important 
to note, however, that additional mechanisms undoubtedly exist.  Mouse caspase-8, 
which lacks Y380, can also stimulate cell motility [1].  Although the mouse homologue 
would not be predicted to be effective in the human cell system, there may be human 
cell contexts in which other mechanisms involving catalytic activity play a more 
significant role, mechanism such as Erk activation mediated by calpain (Chapter 2).  
In this connection, mouse and human caspase-8 both enhance Erk activation 
(Chapter 2 and unpublished data BB and SF).  Furthermore, both mouse and human 
caspase-8 contain Y334, a site predicted to be phosphorylated by mass proteomics  
[29].  This tyrosine, Y298, and other unidentified phosphorylation sites, may be able to 
interact with SH2 domains in a similar manner to Y380. 
 
We propose that caspase-8 utilizes an apoptosis vs. migration switch mechanism.  
This mechanism (Figure 8) utilizes caspase-8 being phosphorylated by src or upon 
EGF treatment to block apoptotic autoprocessing [5].  We have shown here that this 
phosphorylation is important in the promotion of cell migration.  This mechanism 
would therefore demonstrate the coordination of caspase-8 phosphorylation blocking 
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apoptosis and allowing the interaction of caspase-8 with p85 to promote cell migration, 
switching caspase-8 from an apoptotic to a migratory factor.   
 
Caspase-8 could regulate PI3K-mediated cell migration [30-32] through at least two 
different pathways. First, caspase-8 could affect PI3K catalytic activity (reviewed in 
chapter 1). Second, caspase-8 could affect the activation of Rac or cdc42 that is 
directly complexed with p85 [14, 26].  One scenario for this involves the p85 
interaction with Rac/cdc42 via Abi1 [26]; however we could not reproduce Abi1 
mediated Rac activation in our system (data not shown).  The ability of caspase-8 to 
relocalize upon EGF stimulation does not allow us to exclude the possibility that 
caspase-8 is promoting localized PI3K activation.  The lack of effect of caspase-8 on 
Akt phosphorylation does not support a localized PI3K activation, but rather supports 
a Rac/CDC42 activating mechanism.  Details of this mechanism are being elucidated 
currently.  
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Figure 1 
 
 
 
 
 
Figure 1:  Caspase-8 expression is maintained in human tumors.  Two western blots (G-
Biosciences) containing alternating lanes of total protein (50 micrograms) from the indicated 
matched normal or tumor samples were probed with antibodies against caspase-8 or β-actin. 
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Figure 2 
 
 
 
Figure 2:  Caspase-8 enhancement of cell adhesion/motility is dependent on tyrosine-
380, but independent of catalytic activity or autoproteolytic processing. For these 
experiments, the caspase-8-null cell line NB7 was infected with retroviral caspase-8 
expression constructs as indicated and assayed for motility or adhesion. A, pro-caspase-8 
rescues adhesion. Cells were assayed for kinetics of adhesion to fibronectin using ECIS; the 
slopes of the linear portion of the ECIS tracing are plotted; note that the fold stimulation of 
adhesion is similar to that of wild-type caspase-8 reported previously (2). Cas8DA, the 
uncleavable caspase-8 mutant, D374A/D384A; vector, pBABE-puro. B, the catalytic activity of 
caspase-8 is not required and the phosphorylation site Y380 is critical for cell adhesion. An 
ECIS adhesion assay comparing the wild-type (wt), catalytically inactive (C360A), or the 
phosphorylation site– defective mutant of inactive (Y380F/C360A) caspase-8 is shown. P 
values for the difference between the indicated samples are shown. C, pro-caspase-8 
promotes cell motility, which is dependent on Y380. A single cell-motility assay is presented as 
a radial plot indicating distance (not direction) of migration. DA, the uncleavable mutant 
D374A/D384A; Y380F/DA, the phosphorylation site-defective/uncleavable double mutant; 
vector, pBABE-puro. D, inactive caspase-8 promotes cell motility, which is dependent on 
Y380. C360A, catalytically inactive caspase-8; Y380F/C360A, the phosphorylation site–
defective/catalytically inactive double mutant caspase-8. 
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Figure 3 
 
Figure 3.  Caspase-8 interacts with p85. A, a phosphorylated peptide spanning caspase-8 
Y380 reveals candidate interaction partners including p85.  Experiment was performed by SF. 
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Figure 3.  Caspase-8 interacts with p85. B.  Phosphotyrosine 4G10 analysis of caspase-8 s-
tag pulldowns on A431 cells +/- s-tag caspase-8 for detection of caspase-8 phosphorylation.   
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Figure 3.  Caspase-8 interacts with p85.  C.  A431 s-tag pulldowns probed for p85.  Stable 
A431 + caspase-8 s-tag (presumably phosphorylated caspase-8 when treated with EGF) 
interacted specifically with p85 when compared to control A431 cells treated with EGF.
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Figure 3.  Caspase-8 interacts with p85.  D,  Direct in-vitro interactions of caspase-8 +/- 
phosphorylation with GST-p85 but not with GST alone.   
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Figure 4 
 
 
 
Figure 4:  Caspase-8–p85 interaction contributes to Rac activation but does not 
enhance Akt activation. A, caspase-8–p85 interaction contributes to Rac activation. NB7 
cells rescued with uncleavable caspase-8 containing Y380 (Y) or F380 (F) were trypsinized, 
attached to fibronectin-coated dishes for the indicated times, and lysates were assayed for 
total or activated Rac. Bottom, a plot of activated Rac to total Rac ratios derived by 
densitometry; an additional experiment produced similar results. The average fold increase of 
Y380 versus F380 at 25 min was 1.67 F 0.14. D374A/D384A, uncleavable caspase-8 mutant; 
D374A/D384A/Y380F, uncleavable/phosphorylation site-defective caspase-8 mutant. 
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Figure 4:  Caspase-8–p85 interaction contributes to Rac activation but does not 
enhance Akt activation.  B, caspase-8 does not contribute to Akt phosphorylation. NB7 cells 
with the indicated caspase-8 constructs were serum-starved, stimulated with EGF, and 
assayed for Akt serine-473 phosphorylation by Western blotting. Densitometry of phospho-Akt 
and total Akt were used to derive ratios, which were plotted here; a lack of effect of caspase-8 
on Akt phosphorylation was also observed with matrix-reattachment and serum re-addition 
(data not shown). 
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Figure 5 
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Figure 5:  Caspase-8 relocalizes to cell periphery upon EGF treatment and colocalizes 
with rhodamine-labeled EGF (rh-EGF). A.  Rh-EGF treatment colocalizes with HA-C360A 
caspase-8 in A431 cells 
+rh-EGF 
-rh-EGF 
HA-cas8            Rh-EGF 
  DAPI                  DAPI               Merged 
 111
B 
 
 
 
Figure 5:  Caspase-8 relocalizes to cell periphery upon EGF treatment.  B.  HA-C360A 
caspase-8 localizes to the cell periphery upon EGF treatment.  MTLNs were serum starved 
and treated with 100nM EGF for 5 minutes and IF done for HA and actin. 
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Figure 5:  Caspase-8 relocalizes to cell periphery upon EGF treatment.  C.  Caspase-8 
does not influence EGFR phosphorylation.   
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Figure 6 
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Figure 6.  D285H, a naturally occurring SNP does not influence cellular motility or 
adhesion.  Upper panel single cell random migration of NB7 with D285H, DA, or pBabe puro 
vector control expression.  Lower panel – slope of ECIS adhesion assay.  The slope 
represents cell adhesion and spreading across time.   
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Figure 7 
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Figure 7.  D302H, a mutation adjacent to a YXXM motif influences cellular motility and 
adhesion.  Upper panel single cell random migration of NB7 with D302H, wt, or pBabe puro 
vector control expression.  Wt caspase-8 expressing cells migrate better than D302H cells.  
Lower panel – slope of ECIS adhesion assay.  The slope represents cell adhesion and 
spreading across time.  Wt cells attach and spread faster than D302H expressing cells. 
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Figure 8 
 
 
 
Figure 8:  Caspase-8 is involved in a apoptosis motility switch.  The phosphorylation of 
caspase-8 by Src [5] blocks the first apoptotic autocleavage event of caspase-8’s progression 
to apoptosis [6].  Phosphorylated caspase-8 is able to promote interaction with the p85 subunit 
of PI3K and promote cell migration. 
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Chapter 4 
Caspase-2 promotes cellular adhesion, FAK 
activation, and the breakdown of actin stress 
fibers 
 121
Abstract 
Caspase 2 plays important roles in DNA damage-induced, detachment-induced, and 
heat shock-induced apoptosis.  Additional biologic functions are likely; while the 
developmental phenotype of caspase 2 knockout mice is normal, it is often the case 
that the same gene knockout examined in different mouse strains has varying effects.   
Here, we demonstrate that caspase 2 has additional roles in the cell beyond 
apoptosis.  In this study we demonstrate that caspase 2 promotes cell-matrix 
adhesion focal contact formation and FAK phosphorylation.  Caspase 2 also 
influences stress fiber integrity in response to protein kinase-C activation.  Insights into 
the mechanism whereby caspase 2 influences cytoskeletal processes with emphasis 
on Rho/ROCK/LIMK/cofilin and Rho/ROCK/MLC pathways are discussed herein.   
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Introduction 
Potential non-apoptotic roles for caspase 2 stem from studies of DRONC.  DRONC, 
the Drosophila homolog of caspases 2 and 9, is another caspase with a non-apoptotic 
function.  DRONC and its inhibitor, DIAP1 (Drosophila inhibitor of apoptosis 1) are 
connected to border cell migration during Drosophila development though interaction 
of DIAP1 with the Rac pathway [1].  Regulation of this function is through DmIKKε, an 
antagonist of DIAP [2, 3]  that suppresses actin polymerization [4]; other factors may 
be involved.   
 
Non-apoptotic roles are emerging for caspase 2 as well.  Caspase 2 is involved in the 
SREBP mediated increase of lipid levels in that the siRNA knock down of caspase 2 
actually inhibits lipid amplification [5].  Interestingly, cholesterol-lowering drugs, statins 
(e.g. lovastatin), increase caspase 2 gene expression [5] and alter the actin 
cytoskeleton through caspase 2 [6].  This process may be mediated through a 
caspase-2-RhoB interaction [7].    
 
Caspases are also associated with Rho kinase (ROCK) in both apoptotic and non-
apoptotic contexts.  ROCK I cleavage by caspases is associated with apoptotic 
membrane blebbing [8].  ROCK II is also associated with myosin light chain (MLC) 
contractility and membrane blebbing [9].  ROCKII is also associated with a potentially 
nonapoptotic function of caspase 2.  Thrombin-induced ROCK activation and ROCKII 
cleavage has been proposed to be mediated by caspase-2 [10]. 
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Taken together, caspase 2 control of cytoskeletal contractility and, in turn cell 
adhesion and stress fiber dynamics, though the RhoA/ROCK/MLC and/or 
RhoA/ROCK/LIMK/cofilin/actin pathway is not unlikely [11-14].  This chapter will 
examine the relationship of caspase-2 with cellular adhesion and stress fiber 
dynamics and address possible mechanisms. 
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Experimental Procedures   
 
Cell lines: The caspase 2 deficient and wild type MEF cells (C2-/- and C2+/+ 
respectively) were provided by Dr Andreas Strasser [15].  These were immortalized by 
infection with an SV40 T-antigen retroviral construct.  To generate rheoswitch-
inducible caspase-2 cell lines, a mouse caspase-2 expressing derivative of the 
rheoswitch vector pNEBR-X1 was constructed by subcloning wild type caspase-2 
(provided by Sharad Kumar) into the pNEBRX1 vector.  The caspase-2-X1 construct, 
pBabe puromycin construct and inducing vector pNEBR-R1 were linearized at a single 
cut site in a non-coding portion of the vector.  Co-electroporation was done using the 
Rheoswitch vectors and puromycin as a drug selection marker.  Electroporation is 
preformed using the Amaxa Biotechnology Nucleofector II.  Clones of each cell 
construct were selected with 1.5µg/mL puromycin (Calbiochem), isolated, and 
screened for induction. 
 
Adhesion assays:   Electrical Cell-Substratum Impedance Sensing (ECIS).  Cells 
were counted (5x10^5 cells/well) and let attach to the chambers (~1cm2) of a ten-
electrode ECIS array (Applied Biophysics, Troy, New York; www.biophysics.com) that 
were pre-coated with fibronectin.  Adhesion was done in DMEM in the absence of 
serum and was observed until a steady impedance value was reached.   As the cells 
attached to the electrodes of the ECIS array, the impedance increased.  The 
impedance was monitored at 40 kHz frequency and was carried out in triplicate 
chambers.  Data were exported to Excel for calculation of slopes. 
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Adhesion analysis by Immunofluorescence:  Cells are prepared similarly as above 
except that the cells are serum starved over night in 0.5% FBS containing DMEM.  
Cells are then attached to 15µg/mL fibronectin coated cover slips and are fixed using 
4% paraformaldehyde in PBS.  Immunofuorescent preparation/staining is then done 
(see below). 
 
Adhesion for protein activation:  Cells serum starved over night in 0.5% FBS 
containing DMEM and let attach to 15ug/mL fibronectin coated wells.  Wells were 
covered with matrix over night and then remaining well surfaces were blocked in 3% 
BSA containing DMEM for 2 hours.  Cells are then detached from wells using TrypLE 
Express (Invitrogen) and resuspended in 0.5% FBS, 3%BSA containing DMEM.  Cells 
are then allowed to attach for the designated time course and lysed with 5% β-
Mercaptoethanol containing laemmli sample buffer.  Western blots of lysates were 
then performed using primary antibodies:  cofilin, phospho-cofilin (Cell Signaling), 
myosin light chain (from R. Wysolmerski), phospho-myosin light chain (Cell Signaling), 
focal adhesion kinase, phospho-focal adhesion kinase (Y397, Sigma)  or RhoA (Santa 
Cruz Biotechntology) followed by species specific secondary HRP conjugated 
secondary antibodies (Zymax).   
 
PMA treatment:  Cells were grown to equal but sub-confluent densities and serum 
starved for at least 8 hours before 0.1µM PMA treatment.  The PMA was prepared in 
warm serum free media, which replaced the serum starving media on the cells for the 
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PMA treatment time course.  Cells were then lysed for western blot analysis.  If the 
samples were for immunofluorescence (IF), the cells were initially attached to glass 
cover slips and then treated similarly through PMA treatment.  The cells were then 
fixed with paraformaldehyde and prepared for IF. 
 
Immunofluorescence:  Cells that were fixed to cover slips were permeabilized with 
0.1% Triton X-100.  4G10 phosphotyrosine (Upstate) or vinculin (Sigma) primary 
antibodies were used and Alexa-488 labeled secondary antibody (Pierce) was 
applied.  For actin staining, rhodamine phalloidin was applied with the secondary 
antibody.  Cover slips were then mounted with Vectashield mounting media with DAPI 
(Vector Labs).  Slide analysis was performed using a Zeiss Axiovert 200M microscope 
with associated AxioVision software (Carl Zeiss, Göttingen Germany) for image 
analysis. 
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Results 
Caspase 2 promotes cellular adhesion.  Cellular adhesion was compared by ECIS 
using RSL1-induced vs uninduced caspase-2-rheoswitch cell lines, in which induced 
expression was verified by western blotting (figure 1A).  Caspase 2 expression 
promoted cellular adhesion to matrigel (BD Biosciences, Figure 1B, 1C) and 
fibronectin (Figure 1D).  Similar results were obtained comparing caspase 2 wt and 
knock out MEFs (data not shown).   
 
To further characterize caspase-2 effects on cellular adhesion, the kinetics of focal 
contact formation were also examined.  At 16 minutes of adhesion, focal complex 
formation was increased in caspase 2 expressing cells above that in the uninduced 
cells (Figure 2).  Both vinculin and phosphotyrosine staining yield similar results.  
Staining patterns at 26 minutes of adhesion were consistant with the trends witnessed 
at 16 minutes but were not as striking (data not shown).   
 
Caspase-2 promotes focal adhesion kinase activation upon adhesion.  A time 
course of adhesion, comparing the uninduced vs induced caspase-2-Rheoswitch  
cells, also yields a difference in the rate of focal adhesion kinase (FAK) 
phosphorylation on tyrosine 397 (Figure 3).  Similar results were obtained comparing 
caspase 2 wt MEF and caspase 2 knock out cells (unpublished data SMF).  Caspase 
2 wt MEFs are shown in Figure 3 for comparison to the induced caspase-2-
Rheoswitch cells. 
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These results suggest that caspase-2 has an important role in mediating cellular 
adhesion.  Caspase-2 may be influencing FAK after engagement of integrins directly.  
Due to the manner in which the FAK activation assays were conducted, it is not known 
if FAK is being directly affected or whether caspase-2 is influencing another 
cytoskeletal component to mediate FAK activation. 
 
Caspase 2 influences stress fiber integrity.  Using phorbol esters to mimic DAG 
signaling in cells, PKC becomes activated.  This activation leads to Src activity and 
cytoskeletal reorganization, such as the breakdown of stress fibers [16, 17].  To 
determine whether caspase 2 affected this pathway a comparison of phorbol 12-
myristate 13-acetate (PMA) treatment of caspase 2 inducible MEF was performed 
(Figure 4).  Surprisingly, caspase 2 null cells were non-responsive to the stress fiber 
degrading effects of PMA.  This finding is novel because it shows caspase 2 
mediating stress fiber breakdown in the absence of an apoptotic stimuli.   Similar 
results were found in MEFs using a vdVAD capsase-2 inhibitor (Figure 4C).  
Interestingly, the inhibition of caspase-8 by IETD was similar to wild type MEF 
suggesting that regulation of stress fiber dynamics is unique to the initiator caspase-2. 
 
How does caspase-2 alter the cytoskeleton?  Caspase 2 has been linked to 
several proteins that alter the cytoskeleton (ROCK, Rho, spectrin etc).  Rho/ROCK 
have a strong association with focal contact formation (reviewed in [18]) and ROCK 
cleavage is shown to be mediated by caspase 2 [10].   Interestingly, procaspase-2 can 
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be catalytically active [19], perhaps allowing it to cleave ROCK in this non-apoptotic 
context.  
 
To check the ability of caspase 2 to cleave ROCK and look at overall ROCK activity in 
our system we assesed ROCKII cleavage in the RheoSwitch inducible caspase 2 cells 
(Figure 5).  We stimulated serum starved cells with thrombin and performed a western 
blot on their lysates.  ROCK activity was also analyzed in the context of cellular 
adhesion.  Since we saw a striking difference in FAK phosphorylation (Figure 3), we 
used a similar time line to detect ROCK cleavage.  Though preliminary, in our hands, 
caspase-2 promoted thrombin stimulated ROCK cleavage (Figure 5) because there is 
a decrease in total ROCK protein (although there was no evidence of ROCK cleavage 
products, perhaps due to limitations of the antibody or sensitivity of this western blot).  
Note also that the equal loading of this western requires confirmation with internal 
loading controls, and that the ROCKII protein migrated as a larger protein (~180kDa) 
than would be predicted from its molecular weight (160kDa), although the same size 
band was observed using two different antibodies (data not shown).  
 
RhoA activation was also analyzed.  Adhesion is influenced upstream of ROCK by 
RhoA.  During initial adhesion, RhoA activity decreases transiently then increases 
(reviewed in [18]). RhoA experiments seeking activation of RhoA upon cellular 
adhesion were initially unsuccessful.  We were unable to detect an effect of caspase-2 
upon RhoA activation following LPA stimulation (YJ Cho, unpublished data).    When 
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combined, the results suggest that the effect of caspase-2 may be downstream of 
RhoA, at the level of ROCKII.   
 
Cofilin and MLC phopshorylation are downstream of ROCK.  ROCK, when active, 
activates LIMK which then phosphorylates cofilin rendering it inactive [14].  We 
predicted that since caspase 2 null cells do not break down stress fibers as readily 
upon PMA treatment that they would not inactivate ROCK, thus not alter the 
phosphorylation of cofilin.  Neither cellular adhesion nor PMA treatment altered the 
levels of phosphorylated cofilin between samples with and without caspase-2 (Figure 
6).   These results suggest that cofilin is not altered, nor is the LIMK/cofilin pathway 
being affected due to unaltered cofilin phosphorylation status as a readout. 
 
ROCK activity is noted to increase the phosphorylation of MLC and promote 
maintenance focal adhesions and stress fibers under normal conditions [11].  LPA 
stimulation did not alter MLC phosphorylation in the context of caspase-2 expression 
(unpublished data YJ Cho).  The affect of adhesion with caspase-2 upon MLC 
phosphorylation has yet to be determined.  Caspase-2 did not influence 
phosphorylation of myosin light chain upon PMA treatment (Figure 7).     
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Discussion and Future Studies   
Caspase-2 influences cytoskeletal processes through the promotion of cellular 
adhesion and stress fiber breakdown.  Present, developing literatures on caspase-2 
propose its connection to Rho/ROCK signaling pathways [7, 10].  In the context of 
cellular adhesion or stress fiber breakdown, caspase-2 did not alter Rho/ROCK/MLC 
or Rho/ROCK/LIMK/cofilin pathways.  While the pathway studies are preliminary they 
do not suggest that caspase-2 was required for their proper activation/execution.   
 
The future of this project involves elucidation of the pathway in which caspase-2 is 
influencing cytoskeletal dynamics.  Caspase-2 catalytic activity may be required, as 
seen in Sapet et al [10], or it may be involved independent of catalytic activity as was 
seen with caspase-8 (Chapter 3).  Proteomic screens using a dual tagged (FLAG and 
S-tag) caspase-2, similar to what is being done with caspase-8, will be done to identify 
potential interaction partners.  Caspase-2 may influence cellular adhesion and stress 
fiber dynamics via separate mechanisms.  The inhibition of caspase-2 was able to 
mimic caspase-2 knock outs in the maintenance of stress fibers upon DAG like 
signaling.  This suggests that caspase-2’s catalytic activity may be required for stress 
fiber dynamics.   
 
Caspase-2 knock out MEFs also have an accumulation of multinucleate cells in 
comparison to wild type MEFs (B Helfer and YJ Cho, data not shown).  This 
accumulation of multinucleate cells could be due to aberrant mitosis or cytokinesis.  
Collaboration and work being continued by YoungJin Cho Cunnick has established a 
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potential connection of caspase-2 in the regulation of cell cycle progression.  
Caspase-2 expressing cells synchronized by nocodazole and then allowed to go on 
though the cell cycle exhibit an increased activation of CDC42 above caspase-2 knock 
out MEFs.  Furthermore, western blots of caspase-2 from these experiments display 
two bands (a doublet) suggesting a potential caspase-2 modification, such as 
phosphorylation (data not shown).   
 
According to the hypothesis that caspase-2 influences ROCK cleavage, caspase-2’s 
catalytic activity would be required for its downstream cytoskeletal effects.  The data 
using the caspase-2 specific inhibitor zVDVAD-fmk, suggest that the catalytic activity 
of caspase-2 is required for the breakdown of stress fibers.  It is possible that these 
two phenomena are controlled by caspase-2 by both different mechanisms and forms 
of caspase-2.  Another hypothesis was also considered; Caspase 2 complexes with 
RhoB to alter cellular response to PKC activation.  RhoB has 85% sequence 
homology to both RhoA and RhoC [20].  RhoB is associated with cell survival but has 
been shown to induce stress fibers when over expressed (reviewed [20]).  In studies 
examining the role of lovastatin in cells, the activation of Rho proteins is linked to the 
cytoskeletal changes brought upon by lovastatin treatment [21].  Furthermore, with 
caspase 2, RhoB is shown to be in a complex with caspase 2 upon lovastatin 
treatment [7].  It is possible that caspase 2’s association with RhoB is involved in PKC 
mediated rearrangement of stress fibers.  We tested this hypothesis but were unable 
to distinguish heavy-chain antibody bands from caspase-2 detection to confirm proper 
IP, thus caspase-2 may interact with RhoB to influence cytoskeletal dynamics.  Should 
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caspase-2 interact with RhoB [7], its response may be via this interaction, suggesting 
a noncatalytic mechanism.   
 
The recent connection of caspase-2 in cytoskeletal damage induced apoptosis [22] is 
of great relevance to our studies.  The results of this study further support our 
connection of caspase-2 to cytoskeletal dynamics but also introduces additional 
means for which caspase-2 can be bringing about its influence.  It is possible that a 
lack of caspase-2 expression, which allows abnormal cytoskeletal activities to occur, 
does so by preventing cell death, which would normally occur in caspase-2 expressing 
cells.  The lack of apoptosis induction in the caspase-2 null cells would therefore be 
allowing these abnormalities to manifest.  Should caspase-2 expression exist solely 
for induction of apoptosis, tumors would be predicted to decrease its expression.  
Reasons for both its apoptotic and non-apoptotic reduction exist in gastric cancer and 
in leukemia.  In the case of leukemia, lack of cellular adhesion would not be a reason 
to decrease caspase-2 expression, evasion of apoptosis such as DNA damage 
induced apoptosis would be beneficial.  Accordingly, decreased caspase-2 expression 
has been linked to drug resistance in childhood acute lymphoblastic leukemia [23].   
Loss of caspase-2 in gastric cancer [31] is understandable in terms of decreased 
anoikis.  Since cells that are shed from the intestinal lining normally undergo anoikis 
[24], evasion of apoptosis induction along with a decreased adhesion would be 
beneficial to cancer in this context.    
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Similar proteomic studies are going to be performed with caspase-2 to determine 
unique protein interactions that may influence cytoskeletal dynamics, cell cycle 
progression, or apoptosis induction via the cytoskeletal disruption mechanism 
discussed above.  Caspase-2 protein interactions will be able to distinguish between 
non-apoptotic and apoptotic roles, aid in RhoB and CDC42 hypotheses, and help 
determine whether it is via caspase-2’s catalytic activity it is producing its effects.  .   
 
A prediction for why caspase-2 knock out MEFs are not embryonic lethal, is that MEF 
still have expression of caspase-9, which due to its structural similarity may be able to 
compensate for the loss of caspase-2 [25, 26].  Humans with a caspase-8 inactivating 
mutation exhibit T-cell immunodeficiency, but are viable [27].  Capase-10 is credited in 
part for this phenomenon, in that it is structurally similar to caspase-8 and believed to 
be partially redundant [26, 28-30].  It will be interesting to see what, if any non-
apoptotic roles exist for caspase-9 and if any of them coincide with those exhibited 
with caspase-2.   
 
The significance of this project is evident in caspase 2’s effects on cytoskeletal 
processes.  While few cancers are noted to decease the presence of caspase 2 [23, 
31] a tumor screen (Genotech) showed that others maintained if not increased 
expression of caspase-2 (Figure 8);  this project provides information to why it would 
be beneficial for cells to alter caspase-2 expression.  A decrease in cellular adhesion 
and altered cytoskeletal processes could have several cellular ramifications, such as 
the generation of multinucleate cells through unsuccessful cytokinesis [32, 33].  Future 
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continuation of this project has the potential to develop into insights on caspase-2’s 
influence over the cytoskeleton both under non- and apoptotic circumstances.  
Additionally, this project will be able to provide insight into determining if caspase-2 
expression will alter patient survival in addition to apoptosis.   
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Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  Caspase-2 promotes cellular adhesion.  A) Verification of caspase-2 induction.  
Cells are grown to confluence +/- inducer and then lysed.  B) ECIS plot of induced caspase-2 
(expressing) cells (solid line) and uninduced cells (dashed line).  The two lines represent the 
averages of each of three wells (X axis time, Y impedance). As cells attach to the plates 
electrodes the impedance values increase.  Panel B is adhesion to Matrigel (BD Biosciences).  
C) Excel plot of the slope within the dashed box in panel B.  Caspase-2 expressing cells 
attach faster than those lacking caspase-2.  D) Excel plot of the slope of cells attaching in 
ECIS to fibronectin (Calbiochem). 
Sl
op
e 
(o
hm
s/
m
in
) 
0
2
4
6
8
10
12
+RSL1 
-RSL1 
 
180
185
190
195
200
205
1 61 121
Time (min) 
+R
SL
1
-R
SL
1
W
t c
on
tro
l
Im
pe
da
nc
e 
(o
hm
s)
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
RSL1+
RSL1-
Sl
op
e 
(o
hm
s/
m
in
) 
 137
Figure 2 
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Figure 2:  Caspase-2 promotes focal contact formation.  A) Grading scale for degree of 
focal contact formation.  0= no contacts  1= few, faint contacts  2= contacts forming around the 
cell  3= bright mature contacts surrounding the cell.  B) Graph of the degree of focal contact 
formation to fibronectin at 16 minutes of adhesion determined by vinculin staining.  C) Degree 
of focal contact formation based upon phospho-tyrosine staining.   
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Figure 3 
 
 
Figure 3:  Caspase-2 promotes FAK phosphorylation at Y397 upon cellular adhesion.  
Caspase-2 wt and induced caspase-2 expressing cells showed pFAK levels above the 
uninduced, non-caspase-2 expressing cells.  Upper panel is of the FAK western blot and 
densitometry plot of the ratio pFAK to total FAK levels is below.  
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Figure 4 
 
 
 
Figure 4:  Caspase-2 promotes the loss of stress fibers upon PMA/TPA treatment.  Wild 
type caspase-2 inducible cells (C2Rwt) both induced (+RSL1) and uninduced (-RSL1) in 
comparison with wild type MEF (caspase-2 wt) were untreated (time 0) and treated with PMA 
for 10, 20 minutes.  Caspase-2 uninduced cells did not break down stress fibers where as the 
wild type and induced cell lines did show breakdown of stress fibers (top).  
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Figure 4:  Caspase-2 promotes the loss of stress fibers upon PMA/TPA treatment.  B) 
Graph representing the percentage of cells where there was a loss of stress fibers.  At both 10 
and 20 minutes caspase-2 unexpressing cells demonstrate retention of stress fibers where as 
caspase-2 expressing cells showed a loss.   
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Figure 4:  Caspase-2 promotes the loss of stress fibers upon PMA/TPA treatment.  
C)  Caspase-2 inhibition (vdDAD) in wt MEFs produced similar results to caspase-2 
unexpressing cells. Caspase-8 inhibition (IETD treated) produced similar results to wild type 
MEFs. 
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Figure 5 
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Figure 5:  Caspase-2 expression does not alter ROCKII cleavage.  A) Caspase-2 did 
not alter thrombin (1 IU/mL – Enzyme Research Laboratories Inc) stimulation induced 
ROCKII cleavage.  Interestingly, ROCKII cleavage was absent after cleavage.  This result 
is representative of two separate experiments.  B) Cellular adhesion +/- caspase-2 did not 
produce a striking difference in ROCKII cleavage. 
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Figure 6 
   
 
Figure 6:  Cofilin phosphorylation is not substantially altered by caspase-2 expression 
neither in both short and long adhesion time courses nor upon PMA treatment.   Upper 
left shows both total and phosphorylated cofilin upon a short adhesion time course (same 
used for p-FAK analysis), upper right shows the same during a longer adhesion time course.  
Lower panel shows total and phospho-cofilin upon PMA treatment.  The same time course 
and dose of PMA were used as was done in figure 4. 
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Figure 7 
 
 
 
 
Figure 7:  Phosphorylation of myosin light chain does not differ with caspase-2 
expression upon PMA treatment.  Wild type MEF in comparison to caspase-2 knock out 
MEF upon PMA treatment exhibit no change levels of phospho-MLC 
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Figure 8 
 
 
Figure 8:  Tumor tissues do not lose caspase-2 expression.  Genotech blot comparing 
normal and tumor tissue samples.  Blots were probed for caspase-2 and compared to β-actin 
as a loading control.   
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Discussion 
The field of non-apoptotic caspases is an area that until recently has not received its 
due attention.  The executioners of the cell are being found to have roles in 
development, differentiation and cytoskeletal dynamics.  The balance of life and death 
is often challenged in the occurrence of cancer.  Our studies demonstrate signaling 
pathways that, in the context of cancer cells resistant to apoptosis, may actually 
contribute to tumor progression.  Specifically, our studies demonstrate the roles of 
caspase-8 and caspase-2 in cell adhesion, migration, and cytoskeletal response to 
phorbol esters.  Our work, along with others, highlights the impact that the expression 
of these caspases can have in normal cells and in cancer progression along with how 
their expression can influence potential therapy options.   
 
Caspase-8 may influence cellular adhesion/migration in a cell context dependent 
mechanism or via multiple pathways.  In chapter 2, we examined caspase-8’s role in 
adhesion and migration and suggested a calpain dependent mechanism.  In chapter 
3, we showed that caspase-8 interacts directly with p85 in a caspase-8 phospho-Y380 
dependent manner to promote adhesion, migration, and Rac activation.  
 
Discovering the relative contributions of these apparently distinct mechanisms, and 
possible connections between them, is the focus of current and planned investigations 
in the lab.  Caspase-8 may be acting via dual mechanisms to promote motility.  In our 
first study, many experiments were peformed using knock out MEFs.  Mice lack a very 
important factor - the Y380 residue [1].  Yet, in these cells the presence of murine 
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caspase-8 still promotes cellular migration.  The ability to promote calpain activation 
and Erk activity (and thus the proposed pathway of caspase-8 ÆMEKK1 ÆErk 
Æcalpain) is not limited to murine cells (Chapter 2) making this mechanism of action 
likely to be involved in the promotion of migration/adhesion.   
 
Erk activation is involved in many aspects of cell migration, including calpain activation 
and phosphorylation of FAK, MLCK, and paxillin (reviewed in the introduction and [2]).  
In cell systems where the proposed caspase-8/MEKK1/Erk/calpain mechanism 
predominates (eg. mouse fibroblasts), the catalytic activity of caspase-8 would be 
required for cleavage of MEKK1 and subsequent stimulation of Erk.  Consistent with 
the need for catalytic activity, a recent publication highlights basal caspase activity that 
promotes glioblastoma invasion and migration [3].  In this report, caspase activity is 
required for invasion and migration.  Our experiments where we reconstituted 
Rheoswitch-inducible expression of catalytically active vs. inactive caspase-8 mutants 
in knockout MEFs and assayed for cell migration have produced ambiguous results, 
which require further investigation.  Another strategy that we are going to employ for 
testing the catalytic requirement of caspase-8 is to reconstitute MEKK1-knockout 
fibroblasts with either wild-type or caspase uncleavable mutant forms of MEKK1 to be 
assayed for their ability to restore cell migration and adhesion; these experiments are 
underway in our laboratory.   
 
If caspase-8 catalytic activity and/or MEKK1 cleavage is not found to be required in 
certain cell lines, another possibility, in addition to the caspase-8-p85 interaction 
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discussed extensively herein, for promotion of migration is that additional proteins 
containing SH2 domains may interact with caspase-8 Y334, a residue which is also 
phosphorylated [4].  Proteins that may interact with this phosphorylated residue and 
others that may interact with phospho-Y380 are expected to be identified by proteomic 
analysis.   
 
In support of capsase-8 acting via multiple mechanisms to promote cell migration, 
CD95 has been connected to migration and invasion utilizing similar mechanisms.  
CD95 (Fas/Apo-1), is a death receptor responsible for the formation of the death 
inducing signaling complex (DISC) [5] to promote apoptosis.    CD95 signaling is 
nonapoptotically associated with invasion and motility through NF-kappaB, Erk and 
caspase-8 signaling [6] upon stimulation by FasL.  In the case of CD95, another paper 
in the literature supports our idea that caspase-8 autoactivation is not required for its 
promotion of cell motility:  the anti-APO-1 antibody, when added to cells both 
promotes motility and Erk activation but does not induce apoptosis or processing of 
procaspase-8 [7].  Note that this result does not say whether catalytic activity of 
caspase-8 is required or not, as procaspase-8 can be catalytically active under some 
circumstances [8].  A recent publication challenges the involvement of caspase-8 in 
this process.  They state that Fas-induced cell migration can occur in some lines 
independent of caspase-8 recruitment to the DISC, suggesting that in some contexts, 
Fas may stimulate migration independently of caspase-8 [9] (although this was based 
on weak evidence only –lack of effect of a caspase-8 inhibitor peptide and lack of 
recruitment of caspase-8 to the DISC). 
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Many cell types, including breast and pancreatic cancer cells, have significant 
caspase-8 activity that could potentially affect cell behavior under non-apoptotic 
conditions [10, 11]. This increased activity may be caused by elevated soluble FASL 
in some cancers, especially those treated with chemotherapeutic agents [12, 13].  The 
maintenance of caspase-8 in many tumor types (Chapter 3, Figure 1), along with 
increased caspase-8 activity brings up an interesting dilemma in selection of cancer 
therapies.  Any therapy (eg TRAIL [14-18]) that activates caspase-8 in apoptosis-
resistant tumor cells, whether by accident or design, has the potential of stimulating 
tumor cell migration and invasion, undesirable effects.   
 
Caspase-2, another initiator caspase, examined in Chapter 4, is important for cellular 
adhesion and for stress fiber break down upon phorbol-ester treatment.  While initial 
hypotheses to identify the mechanism of caspase-2’s actions fell short, they did 
provide reason to take a second look at the proposed mechanisms as well as insight 
to other potential avenues for caspase-2 action.   
 
According to the hypothesis that caspase-2 influences ROCK cleavage, caspase-2’s 
catalytic activity would be required for its downstream cytoskeletal effects.  The 
catalytic activity of caspase-2 appears to be required for effect upon stress fiber 
breakdown, because a caspase-2 inhibitor peptide suppressed stress fiber 
breakdown.  This result is consistent with the dependence of ROCKII cleavage on 
caspase-2 that we observed in our preliminary data.  It is also possible that cellular 
adhesion and stress fiber dynamics are controlled by caspase-2 by multiple 
 155
mechanisms or forms of caspase-2.  Should caspase-2 interact with RhoB [19], its 
response may be through this interaction, rather than its catalytic activity.   
 
It is likely that other mechanisms are involved in the regulation of caspase-2 in 
cytoskeletal dynamics.  The data on cofilin and MLC phosphorylation and RhoA 
activation do not suggest that caspase-2 is influencing their pathways of activation 
(Chapter 4 and unpublished data YJC).  We are currently in the process of developing 
a caspase-2-FLAG-S-tag construct to be expressed in knockout MEFs in order to 
perform proteomic analysis for novel caspase-2 interactions, similar to what is being 
done with caspase-8.  Elucidation of novel interactions may be able to explain how 
caspase-2 is regulating cellular adhesion and stress fiber breakdown.   
 
Caspase-2 has recently been associated with cytoskeletal disruption induced 
apoptosis [20], as discussed in Chapter 4.  It is possible that a lack of caspase-2 
expression allows cytoskeletal abnormalities to manifest instead of undergoing 
apoptosis, which would be the case in caspase-2 expressing cells.  It will be 
interesting to see, as this project is continued, whether caspase-2 is able to act 
independently of apoptosis.   
 
Alterations of caspase-2 expression levels also exist in gastric cancer and leukemia 
[21, 22].    According to a screen of normal vs. tumor tissue samples, caspase-2 
expression is often maintained in tumors (Chapter 4, Fig 8), making it an interesting 
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candidate for a non-apoptotic function involved in tumor progression, analogous in 
some ways to the caspase-8 phenomenon.   
 
Our work with caspase-8 and caspase-2 has made a notable contribution to the field 
of non-apoptotic caspase functions.  Our work with caspase-8 was the first to 
demonstrate its role in cell motility and adhesion, as well as the first reported pro-
caspase function, via its interaction with p85.  While the experiments dealing with 
caspase-2 are in the early stages of its development it will be interesting to see how 
the field progresses as our lab and others continue to contribute to its advancement. 
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